UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

(Mark One)

 

[X]

QUARTERLY REPORT UNDERPURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 20182019

 

[  ]

TRANSITION REPORT UNDERPURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission File Number: 000-52635

 

ACCELERIZECFN ENTERPRISES INC.

(Exact name of registrant as specified in its charter)

 

Delaware

20-3858769

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

20411 SW BIRCH STREET,2601 OCEAN PARK BOULEVARD, SUITE 250310

NEWPORT BEACH,SANTA MONICA,

CALIFORNIA 9266090405

 (Address of principal executive offices) (Zip code)

 

(949) 548 2253(310) 314-8804

 (Registrant’s Telephone Number, including Area Code)

 


ACCELERIZE INC.
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X]  No [  ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes [X]  No [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [  ]

Accelerated filer [  ]

Non-accelerated filer [X]

Smaller reporting company [X]

  

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [  ]  No [X]

 

The number of shares outstanding of the registrant’s Common Stock, $0.001 par value per share, as of November 14, 2018,6, 2019, was 66,179,709.99,679,709.

 

When used in this quarterly report, the terms “Accelerize,“CFN Enterprises,” “the Company,” “we,” “our,” and “us” refer to AccelerizeCFN Enterprises Inc., a Delaware corporation. 

 



 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKINGFORWARD LOOKING INFORMATION

 

This quarterly report on Form 10-Q contains certain forward-looking statements. Forward-looking statements may include our statements regarding our goals, beliefs, strategies, objectives, plans, including product and service developments, future financial conditions, results or projections or current expectations. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. For example, when we discuss our pursuitexpectations for 2019, our expectations for revenue sources, costs of strategic transactions including acquisitions, dispositions, capital raisingrevenue and debt restructuring, that our revenues will increase in 2018,expenses going forward, and that we intendwill continue to invest in sales, marketing, product developmentpursue strategic transactions and innovation,opportunities, we are using forward-looking statements. These statements are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause actual results to be materially different from those contemplated by the forward-looking statements. These factors include, but are not limited to, our ability to implement our strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors. Most of these factors are difficult to predict accurately and are generally beyond our control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. The business and operations of AccelerizeCFN Enterprises Inc. are subject to substantial risks, which increase the uncertainty inherent in the forward-looking statements contained in this report. Except as required by law, we undertake no obligation to release publicly the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Further information on potential factors that could affect our business is described under “Item 1A. Risk Factors” contained in our annual report on Form 10-K as filed with the Securities and Exchange Commission, or the SEC, on March 27, 2018April 16, 2019, and in thisour quarterly report on Form 10-Q.10-Q as filed with the SEC on August 16, 2019. Readers are also urged to carefully review and consider the various disclosures we have made in this report and in our annual report on Form 10-K.

 



 

 

CFN ENTERPRISES INC.

(F/K/A ACCELERIZE INC.)

 

INDEX

 

  

Page

 

 

PART I - FINANCIAL INFORMATION:

41

 

 

Item 1.

Financial Statements (Unaudited)

41

 

 

Item 2.

Management’s Discussion and Analysis of Financial Position and Results of Operations

2123

  

  

Item 4.

Controls and Procedures

3031

 

 

PART II - OTHER INFORMATION:

3031

 

 

Item 1A.

Risk Factors

30

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

31

Item 6.

Exhibits

31

 

 

SIGNATURES

32

 



 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

CFN ENTERPRISES INC. 

(F/K/A ACCELERIZE INC.)

CONDENSED CONSOLIDATED BALANCE SHEETS

 

  

September 30,

2018

  

December 31,

2017

 
  

(Unaudited)

     

ASSETS

        
         

Current Assets:

        

Cash

 $1,808,029  $166,883 

Restricted cash

  50,000   50,000 

Accounts receivable, net of allowance for bad debt of $268,923 and $471,144, respectively

  2,130,476   2,692,636 

Prepaid expenses and other assets

  330,455   548,343 

Total current assets

  4,318,960   3,457,862 
         

Property and equipment, net of accumulated depreciation of $788,587 and $775,152, respectively

  63,975   69,405 

Intangible assets, net of accumulated amortization of $2,938,350 and $2,512,203, respectively

  4,624,377   3,925,523 

Other assets

  109,777   123,124 

Total assets

 $9,117,089  $7,575,914 
         

LIABILITIES AND STOCKHOLDERS' DEFICIT

        
         

Current Liabilities:

        

Accounts payable and accrued expenses

 $2,278,096  $2,479,083 

Deferred revenues

  564,002   299,937 

Credit facility, short term

  3,501,487   3,055,812 

Other short-term loan, net of unamortized deferred financing cost of $0 and $0, respectively

  -   1,224,194 

Total current liabilities

  6,343,585   7,059,026 

Credit facility, net of unamortized deferred financing cost of $1,745,491 and $245,584, respectively

  6,404,754   4,402,988 

Other loan, related party net of unamortized deferred financing cost of $180,209 and $0, respectively

  369,791   - 

Other loan net of unamortized deferred financing cost of $744,205 and $82,868, respectively

  2,205,795   267,938 

Other liabilities

  743,750   1,062,500 

Total liabilities

  16,067,675   12,792,452 
         

Stockholders' Deficit:

        

Series A Preferred stock; $0.001 par value; 54,000 shares authorized; None issued and outstanding.

  -   - 

Series B Preferred stock; $0.001 par value; 1,946,000 shares authorized; None issued and outstanding.

  -   - 

Common stock; $0.001 par value; 100,000,000 shares authorized; 66,179,709 and 65,939,709 shares issued and outstanding, respectively

  66,178   65,938 

Additional paid-in capital

  29,371,783   26,301,748 

Accumulated deficit

  (36,326,324

)

  (31,542,684

)

Accumulated other comprehensive loss

  (62,223

)

  (41,540

)

         

Total stockholders’ deficit

  (6,950,586

)

  (5,216,538

)

         

Total liabilities and stockholders’ deficit

 $9,117,089  $7,575,914 
  

September 30,

  

December 31,

 
  

2019

  

2018

 
  

(Unaudited)

     

Assets

 
         

Current assets

        

Cash

 $975,434  $27,295 

Restricted cash

  -   50,000 

Accounts receivable, net

  231,503   - 

Prepaid expenses and other current assets

  3,401   - 

Current assets of discontinued operations

  -   2,336,311 

Total current assets

  1,210,338   2,413,606 
         

Other assets

        

Property and equipment

  3,369   - 

Goodwill

  3,225,817   - 

Other intangible assets

  558,475   - 

Noncurrent assets of discontinued operations

  -   160,246 

Total other assets

  3,787,661   160,246 

Total assets

 $4,997,999  $2,573,852 
         

Liabilities and Stockholders' Equity (Deficit)

 
         

Current liabilities

        

Accounts payable and accrued expenses

 $186,572  $- 

Deferred revenues

  45,041   - 

Current liabilities of discontinued operations

  76,028   6,861,284 

Total current liabilities

  307,641   6,861,284 

Long-term note payable

  482,698   - 

Noncurrent liabilities of discontinued operations

  -   9,185,743 

Total liabilities

  790,339   16,047,027 
         

Commitments and contingencies

        
         

Stockholders' equity (deficit)

        

Series A Preferred stock, $0.001 par value, 500 shares authorized, 500 and 0 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively

  1   - 

Series B Preferred stock, $0.001 par value, 3,000 shares authorized, 3,000 and 0 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively

  3   - 

Common stock, $0.001 par value, 500,000,000 shares authorized, 99,679,709 and 66,179,709 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively

  99,679   66,179 

Additional paid-in capital

  34,031,326   29,498,125 

Accumulated deficit

  (29,836,426)  (42,960,124)

Accumulated other comprehensive income

  (86,923)  (77,355)

Total stockholders' equity (deficit)

  4,207,660   (13,473,175)

Total liabilities and stockholders' equity

 $4,997,999  $2,573,852 

 

See Notes to Unaudited Condensed Consolidated Financial Statements. 

See accompanying notes to unaudited condensed consolidated financial statements

 


 

CFN ENTERPRISES INC.

(F/K/A ACCELERIZE INC.)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

  

Three-month periods ended

September 30,

  

Nine-month periods ended

September 30,

 
  

2018

  

2017

  

2018

  

2017

 
                 

Revenues:

 $5,292,304  $6,065,674  $16,682,730  $18,016,552 

Cost of revenue

  2,042,435   2,749,975   6,865,431   6,660,684 

Gross profit

  3,249,869   3,315,699   9,817,299   11,355,868 
                 

Operating expenses:

                

Research and development

  1,033,707   1,031,878   3,144,106   3,208,434 

Sales and marketing

  1,127,055   1,119,302   3,359,247   3,419,095 

General and administrative

  2,372,359   1,554,982   6,278,522   5,232,896 

Total operating expenses

  4,533,121   3,706,162   12,781,875   11,860,425 
                 

Operating loss

  (1,283,252

)

  (390,463

)

  (2,964,576

)

  (504,557

)

                 

Other income (expense):

                

Other income (loss)

  (222

)

  2   564   744 

Other expense

  (679,663

)

  (305,284

)

  (1,819,628

)

  (863,865

)

Total other (expense)

  (679,885

)

  (305,282

)

  (1,819,064

)

  (863,121

)

                 

Net loss

 $(1,963,137

)

 $(695,745

)

 $(4,783,640

)

 $(1,367,678

)

                 

Net loss per share:

                

Basic

 $(0.03

)

 $(0.01

)

 $(0.07

)

 $(0.02

)

Diluted

 $(0.03

)

 $(0.01

)

 $(0.07

)

 $(0.02

)

                 
                 

Basic weighted average common shares outstanding

  66,177,101   65,520,434   66,019,709   65,356,201 

Diluted weighted average common shares outstanding

  66,177,101   65,520,434   66,019,709   65,356,201 
  

For the Three Months Ended

  

For the Nine Months Ended

 
  

September 30,

  

September 30,

  

September 30,

  

September 30,

 
  

2019

  

2018

  

2019

  

2018

 
                 
                 

Net revenues

 $568,992  $-  $631,712  $- 

Cost of revenue

  381,277   -   414,726   - 

Gross profit

  187,715   -   216,986   - 
                 

Operating expenses:

                

Selling, general and administrative

  600,663   313,536   1,495,492   1,016,368 

Total operating expenses

  600,663   313,536   1,495,492   1,016,368 
                 

Loss from operations

  (412,948)  (313,536)  (1,278,506)  (1,016,368)
                 

Other income (expense):

                

Interest expense

  (2,514)  -   (2,514)  - 

Interest income

  19   25   131   61 

Total other income (expense)

  (2,495)  25   (2,383)  61 
                 

Net loss before provision for income taxes

  (415,443)  (313,511)  (1,280,889)  (1,016,307)

Provision for income taxes

  -   -   -   - 

Net loss from continuing operations

  (415,443)  (313,511)  (1,280,889)  (1,016,307)

Gain (loss) from discontinued operations, net of tax

  1,113   (1,649,626)  14,471,162   (3,767,333)

Net income (loss)

 $(414,330) $(1,963,137) $13,190,273  $(4,783,640)

Preferred stock interest

  60,000   -   66,575   - 

Net income (loss) available to common shareholders

 $(474,330) $(1,963,137) $13,123,698  $(4,783,640)
                 

Net loss from continuing operations per share, basic and diluted

 $(0.00) $(0.00) $(0.02) $(0.02)
                 

Net income (loss) from discontinued operations per share, basic and diluted

 $0.00  $(0.02) $0.18  $(0.06)

Weighted average number of common shares outstanding, basic and diluted

  99,679,709   66,177,101   78,696,193   66,019,709 

 

See Notes to Unaudited Condensed Consolidated Financial Statements.

See accompanying notes to unaudited condensed consolidated financial statements

 


 

CFN ENTERPRISES INC.

(F/K/A ACCELERIZE INC.)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSSINCOME (LOSS)

 

  

Three-month periods ended

September 30,

  

Nine-month periods ended

September 30,

 
  

2018

  

2017

  

2018

  

2017

 
                 

Net loss

 $(1,963,137

)

 $(695,745

)

 $(4,783,640

)

 $(1,367,678

)

                 

Foreign currency translation loss

  (7,166

)

  12,841   (20,683

)

  32,098 

Total other comprehensive loss

  (7,166

)

  12,841   (20,683

)

  32,098 
                 

Comprehensive loss

 $(1,970,303

)

 $(682,904

)

 $(4,804,323

)

 $(1,335,580

)

  

For the Three Months Ended

  

For the Nine Months Ended

 
  

September 30,

  

September 30,

  

September 30,

  

September 30,

 
  

2019

  

2018

  

2019

  

2018

 
                 
                 

Net income (loss)

 $(414,330) $(1,963,137) $13,190,273  $(4,783,640)

Other comprehensive income (loss), net of tax:

                

Foreign currency translation adjustments

  (13,050)  (7,166)  (9,568)  (20,683)

Total other comprehensive income (loss), net of tax

  (13,050)  (7,166)  (9,568)  (20,683)

Comprehensive income (loss)

 $(427,380) $(1,970,303) $13,180,705  $(4,804,323)

 

See Notes to Unaudited Condensed Consolidated Financial Statements.

See accompanying notes to unaudited condensed consolidated financial statements

 


CFN ENTERPRISES INC.

(F/K/A ACCELERIZE INC.)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

 
  

Three Months Ended September 30, 2019

 
                                  

Accumulated

     
                          

Additional

      

Other

     
  

Series A Preferred Stock

  

Series B Preferred Stock

  

Common Stock

  

Paid-in

  

Accumulated

  

Comprehensive

     
  

Shares

  

Amount

  

Shares

  

Amount

  

Shares

  

Amount

  

Capital

  

Deficit

  

Income

  

Total

 

Balance, June 30, 2019

  500  $1   3,000  $3   99,679,709  $99,679  $34,013,702  $(29,362,096) $(73,873) $4,677,416 
                                         

Fair value of warrants issued with promissory notes

  -   -   -   -   -   -   17,624   -   -   17,624 

Preferred stock interest

  -   -   -   -   -   -   -   (60,000)  -   (60,000)

Net loss

  -   -   -   -   -   -   -   (414,330)  -   (414,330)

Foreign currency translation

  -   -   -   -   -   -   -   -   (13,050)  (13,050)

Balance, September 30, 2019

  500  $1   3,000  $3   99,679,709  $99,679  $34,031,326  $(29,836,426) $(86,923) $4,207,660 

  

Nine Months Ended September 30, 2019

 
                                  

Accumulated

     
                          

Additional

      

Other

     
  

Series A Preferred Stock

  

Series B Preferred Stock

  

Common Stock

  

Paid-in

  

Accumulated

  

Comprehensive

     
  

Shares

  

Amount

  

Shares

  

Amount

  

Shares

  

Amount

  

Capital

  

Deficit

  

Income

  

Total

 

Balance, December 31, 2018

  -  $-   -  $-   66,179,709  $66,179  $29,498,125  $(42,960,124) $(77,355) $(13,473,175)
                                         

Fair value of options and restricted stock awards

  -   -   -   -   -   -   70,963   -   -   70,963 

Fair value of warrants

  -   -   -   -   -   -   126,810   -   -   126,810 

Fair value of warrants issued with promissory notes

  -   -   -   -   -   -   62,294   -   -   62,294 

Fair value of repricing adjustment

  -   -   -   -   -   -   104,638   -   -   104,638 

Conversion of debt into Series A Preferred Stock

  500   1   -   -   -   -   499,999   -   -   500,000 

Issuance of Series B Preferred Stock for acquisition of CFN

  -   -   3,000   3   -   -   686,997   -   -   687,000 

Issuance of common stock for acquistion of CFN

  -   -   -   -   30,000,000   30,000   2,670,000   -   -   2,700,000 

Issuance of common stock as payment of interest

  -   -   -   -   3,500,000   3,500   311,500   -   -   315,000 

Preferred stock interest

  -   -   -   -   -   -   -   (66,575)  -   (66,575)

Net income

  -   -   -   -   -   -   -   13,190,273   -   13,190,273 

Foreign currency translation

  -   -   -   -   -   -   -   -   (9,568)  (9,568)

Balance, September 30, 2019

  500  $1   3,000  $3   99,679,709  $99,679  $34,031,326  $(29,836,426) $(86,923) $4,207,660 

  

Three Months Ended September 30, 2018

 
                                  

Accumulated

     
                          

Additional

      

Other

     
  

Series A Preferred Stock

  

Series B Preferred Stock

  

Common Stock

  

Paid-in

  

Accumulated

  

Comprehensive

     
  

Shares

  

Amount

  

Shares

  

Amount

  

Shares

  

Amount

  

Capital

  

Deficit

  

Income

  

Total

 

Balance, June 30, 2018

  -  $-   -  $-   65,939,709  $65,938  $28,543,529  $(34,363,187) $(55,057) $(5,808,777)
                                         

Fair value of options and restricted stock awards

  -   -   -   -   240,000   240   37,137   -   -   37,377 

Fair value of warrants

  -   -   -   -   -   -   101,836   -   -   101,836 

Fair value of warrants issued with promissory notes

  -   -   -   -   -   -   689,281   -   -   689,281 

Net loss

  -   -   -   -   -   -   -   (1,963,137)  -   (1,963,137)

Foreign currency translation

  -   -   -   -   -   -   -   -   (7,166)  (7,166)

Balance, September 30, 2018

  -  $-   -  $-   66,179,709  $66,178  $29,371,783  $(36,326,324) $(62,223) $(6,950,586)

  

Nine Months Ended September 30, 2018

 
                                  

Accumulated

     
                          

Additional

      

Other

     
  

Series A Preferred Stock

  

Series B Preferred Stock

  

Common Stock

  

Paid-in

  

Accumulated

  

Comprehensive

     
  

Shares

  

Amount

  

Shares

  

Amount

  

Shares

  

Amount

  

Capital

  

Deficit

  

Income

  

Total

 

Balance, December 31, 2017

  -  $-   -  $-   65,939,709  $65,938  $26,301,747  $(31,542,684) $(41,540) $(5,216,539)
                                         

Fair value of options and restricted stock awards

  -   -   -   -   240,000   240   113,058   -   -   113,298 

Fair value of warrants

  -   -   -   -   -   -   229,401   -   -   229,401 

Fair value of warrants issued with promissory notes

  -   -   -   -   -   -   2,727,577   -   -   2,727,577 

Net loss

  -   -   -   -   -   -   -   (4,783,640)  -   (4,783,640)

Foreign currency translation

  -   -   -   -   -   -   -   -   (20,683)  (20,683)

Balance, September 30, 2018

  -  $-   -  $-   66,179,709  $66,178  $29,371,783  $(36,326,324) $(62,223) $(6,950,586)

See accompanying notes to unaudited condensed consolidated financial statements


 

CFN ENTERPRISES INC.

(F/K/A ACCELERIZE INC.)     

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

  

Nine-month periods ended

September 30,

 
  

2018

  

2017

 

Cash flows from operating activities:

        

Net loss

 $(4,783,640

)

 $(1,367,678

)

Adjustments to reconcile net loss to net cash used in operating activities:

        

Depreciation and amortization

  461,893   612,639 

Amortization of debt discount and deferred financing cost

  636,125   180,204 

Provision for bad debt

  (202,221

)

  (48,586

)

Fair value of options and warrants

  342,698   633,997 

Loss on sale of fixed assets

  997   902 

Changes in operating assets and liabilities:

        

Accounts receivable

  764,381   (196,315

)

Prepaid expenses and other assets

  147,888   (129,077

)

Accounts payable and accrued expenses

  (415,072

)

  (641,049

)

Deferred revenues

  264,065   18,213 

Other assets

  13,346   (20,016

)

Net cash used in operating activities

  (2,769,540

)

  (956,766

)

         

Cash flows from investing activities:

        

Capitalized software for internal use

  (1,125,000

)

  (1,347,075

)

Capital expenditures

  (31,579

)

  (44,125

)

Proceeds from sale of assets

  750   795 

Net cash used in investing activities

  (1,155,829

)

  (1,390,405

)

         

Cash flows from financing activities:

        

Principal repayments of credit facility and loan

  (2,402,652

)

  (1,653,282

)

Proceeds from credit facility

  5,489,850   1,923,000 

Proceeds from promissory notes

  3,500,000   1,000,000 
Repayments of promissory notes  (1,000,000)  - 

Net cash provided by financing activities

  5,587,198   1,269,718 
         

Effect of exchange rate changes on cash

  (20,683

)

  32,098 
         

Net increase (decrease) in cash

  1,641,146   (1,045,355

)

         

Cash, beginning of period

  216,883   1,730,127 
         

Cash, end of period

 $1,858,029  $684,772 
         

Supplemental disclosures of cash flow information:

        

Cash paid for interest

 $1,133,678  $613,240 

Cash paid for income taxes

 $-  $- 
         

Non-cash investing and financing activities:

        

Fair value of warrants issued in connection with credit facility and promissory notes

 $2,727,577  $104,676 

Repayment of Agility Loan, included in accounts payable

 $-  $25,000 

Capital expenditure included in account payable

 $1,739  $- 

Shares issued for cashless exercise of options and warrants

 $-  $1,868 

Accrued payables and short-term loan directly paid off by credit facility

 $680,149  $- 

Prepaid expenses reclassed to deferred financing cost

 $70,000  $- 

Deferred financing cost incurred in connection with promissory notes

 $75,000  $- 
         

Reconciliation of Cash and Cash Equivalents and Restricted Cash:

        

Cash and cash equivalents at beginning of period

 $166,883  $1,680,127 

Restricted cash at beginning of period

 $50,000  $50,000 

Cash and cash equivalents and restricted cash at beginning of period

 $216,883  $1,730,127 

Cash and cash equivalents at end of period

 $1,808,029  $634,772 

Restricted cash at end of period

 $50,000  $50,000 

Cash and cash equivalents and restricted cash at end of period

 $1,858,029  $684,772 
  

For the Nine Months Ended

 
  

September 30,

  

September 30,

 
  

2019

  

2018

 
         

Cash flows from operating activities

        

Net income (loss)

 $13,190,273  $(4,783,640)

Adjustments to reconcile net income (loss) to net cash used in operating activities:

        

Depreciation and amortization

  52,132   461,893 

Gain on sale of CAKE Business

  (19,473,080)  - 

Amortization of deferred financing cost

  2,512,282   636,125 

Provision for bad debt

  54,264   (202,221)

Fair value of options and warrants

  197,773   342,698 

Loss on sale of fixed assets

  -   997 

Issuance of common stock as payment of interest

  315,000   - 
         

Changes in operating assets and liabilities:

        

Accounts receivable

  (183,558)  764,381 

Prepaid expenses and other current assets

  199,965   147,888 

Other assets

  68,482   13,346 

Accounts payable and accrued expenses

  (2,224,935)  (415,072)

Deferred revenue

  (260,497)  264,065 

Other liabilities

  (602,083)  - 
         

Net cash used in operating activities

  (6,153,982)  (2,769,540)
         

Cash flows from investing activities

        

Capitalized software for internal use

  -   (1,125,000)

Purchase of property and equipment

  (1,751)  (31,579)

Proceeds from sale of fixed assets

  -   750 

Proceeds from sale of CAKE Business

  20,892,667   - 

Payments for acquisition of subsidiary

  (420,000)  - 

Net cash provided by (used in) investing activities

  20,470,916   (1,155,829)
         

Cash flows from financing activities

        

Principal repayments of credit facility and loan

  (11,772,514)  (2,402,652)

Proceeds from credit facility

  900,000   5,489,850 

Payment of preferred stock interest

  (35,000)  - 

Proceeds from promissory notes

  500,000   3,500,000 

Repayment of related party notes

  (300,000)  - 

Repayment of promissory notes

  (2,700,000)  (1,000,000)
         

Net cash (used in) provided by financing activities

  (13,407,514)  5,587,198 
         

Effect of exchange rate fluctuations on cash

  (11,281)  (20,683)
         

Net change in cash and restricted cash

  898,139   1,641,146 

Cash and restricted cash, beginning of the period

  77,295   216,883 

Cash and restricted cash, end of the period

 $975,434  $1,858,029 
         

Supplemental disclosure of cash flow information:

        

Interest paid

 $946,691  $1,133,678 

Income taxes paid

 $-  $- 
         

Supplemental disclosure of non-cash investing and financing information:

        

Fair value of warrants issued in connection with line of credit and promissory notes

 $62,294  $2,727,577 

Capital expenditure included in accounts payable

 $-  $1,739 

Accrued payables and short-term note directly paid off by credit facility

 $-  $680,149 

Prepaid expenses reclassified to deferred financing costs

 $-  $70,000 

Deferred financing costs incurred in connection with promissory notes

 $-  $75,000 

Accrual of preferred stock interest

 $31,575  $- 

Accrued interest reclassed to credit facility

 $62,379  $- 

Warrant repricing adjustment

 $104,638  $- 

Conversion of notes payable to Series A Preferred Stock

 $500,000  $- 

Issuance of Series B Preferred Stock for acquisition of subsidiary

 $687,000  $- 

Issuance of common stock for acquisition of subsidiary

 $2,700,000  $- 

 

See Notes to Unaudited Condensed Consolidated Financial Statements.

See accompanying notes to unaudited condensed consolidated financial statements

 


 

CFN ENTERPRISES INC.

(F/K/A ACCELERIZE INC.)

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

  

 

NOTE 1: ORGANIZATION DESCRIPTIONAND BASIS OF BUSINESS AND GOING CONCERNPRESENTATION

 

Organization

CFN Enterprises Inc., formerly known as Accelerize Inc., or the Company, is a Delaware corporation incorporated on November 22, 2005 ownswhich owned and operatesoperated CAKE, a Software-as-a-Service or SaaS, platform providing online tracking and analytics solutions for advertisers and online marketers.

The Company providesprovided software solutions for businesses interested in expanding their online advertising spend. Effective October 22, 2019, the Company filed a certificate of amendment to its certificate of incorporation with the Secretary of State of the State of Delaware to change its corporate name to CFN Enterprises Inc.

On May 15, 2019, the Company entered into an asset purchase agreement, or the Asset Purchase Agreement, with CAKE Software, Inc., a Delaware corporation and a subsidiary of Constellation Software Inc., an Ontario, Canada corporation (TSX: CSU), or Constellation, pursuant to which the Company agreed to sell substantially all of the assets associated with its CAKE and Journey by CAKE business, or the CAKE Business, to Constellation for a base purchase price of $19,400,000 plus or minus an estimated closing date adjustment based on the net tangible assets of the CAKE Business at the closing, a holdback of $500,000 adjusted pursuant to the terms of the Asset Purchase Agreement and payable on the first anniversary of the closing date, and a three year earnout equal to 30% of the amount that the annual net revenue of the CAKE Business exceeds $13,750,000 and payable within 120 days on each of the first, second and third end of month anniversaries of the closing date. The sale of the assets of the CAKE Business pursuant to the Asset Purchase Agreement closed on June 18, 2019, and the Company received proceeds of $20,892,667, net of the estimated closing date adjustment.

As of the closing date, Constellation acquired all of the assets used by the Company in the CAKE Business and assumed the Company’s post-closing obligations under certain vendor, customer and other commercial contracts related to the CAKE Business, including the Company’s lease for its headquarters in Newport Beach, California. The Company’s cash and cash equivalents, and the assets associated with its Accelerize trademark, are excluded from the sale of the CAKE Business. Constellation offered employment to certain of the Company’s employees following the closing date.

On May 15, 2019, the Company entered into the Emerging Growth Agreement with Emerging Growth, LLC, or the Seller, pursuant to which the Company acquired certain assets from the Seller related to its sponsored content and marketing business for a purchase price consideration consisting of $420,000 in cash, 30,000,000 shares of the Company’s common stock, and 3,000 shares of Series B preferred stock with a total stated value of $3,000,000 which bears interest at 6% per annum and is convertible into the Company’s common stock at a conversion price to be mutually agreed in the future, without voting rights or a liquidation preference except with respect to default interest.  The securities were issued pursuant to an exemption under Section 4(a)(2) of the Securities Act of 1933, as amended. The closing of the purchase of the assets pursuant to the Emerging Growth Agreement occurred on June 20, 2019.

Subsequent to the closing of the Asset Purchase Agreement on June 18, 2018, the Company’s continuing operations consist of the sponsored content and marketing business from the assets acquired pursuant to the Emerging Growth Agreement.


Going Concern

The accompanying consolidated financial statements have been prepared on a going concern basis which implies the Company will continue to meet its obligations for the next 12 months as of the date these financial statements are issued.  

The Company had working capital of $902,697 and an accumulated deficit of $29,836,426 as of September 30, 2019.  The Company also had a net loss from continuing operations of $1,280,889 during the nine months ended September 30, 2019.

As discussed above, on May 15, 2019, the Company entered into the Asset Purchase Agreement with Constellation under which all the net assets associated with the CAKE Business were sold. The proceeds from the Asset Purchase Agreement were used to pay off the Company’s existing debt, as well as to acquire certain assets in the Emerging Growth Agreement from the Seller related to its sponsored content and marketing business. Management’s plan to continue as a going concern includes raising capital in the form of debt or equity, growing the business acquired under the Emerging Growth Agreement and managing and reducing operating and overhead costs. The Company cannot provide any assurance that unforeseen circumstances that could occur at any time within the next twelve months or thereafter will not increase the need for the Company to raise additional capital on an immediate basis.

These matters, among others, raise substantial doubt about the ability of the Company to continue as a going concern. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern.  

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements include the results of operations of the Company and Cake Marketing UK Ltd., or the Subsidiary. The Company discontinued its operations associated with its CAKE Business and the operations of its Subsidiary in May 2019. These accounts have been presented as discontinued operations in the accompanying unaudited condensed consolidated financial statements. Continuing operations presented in periods prior reflect administrative expenses associated with business insurance, legal and accounting fees that the Company will continue to incur. All material intercompany accounts and transactions between the Company and its Subsidiary have been eliminated in consolidation.

 

These unaudited condensed consolidated financial statements reflect all adjustments including normal recurring adjustments, which, in the opinion of management, are necessary to present fairly the financial position, results of operations, and cash flows for the periods presented in accordance with accounting principles generally accepted in the United States of America, or GAAP. These unaudited condensed consolidated financial statements and notes included herein should be read in conjunction with the Company’s consolidated financial statements and notes thereto for the years ended December 31, 20172018 and 2016,2017, respectively, which are included in the Company’s December 31, 20172018 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission on March 27, 2018.April 16, 2019.  The Company assumes that the users of the interim financial information herein have read, or have access to, the audited consolidated financial statements for the preceding period, and that the adequacy of additional disclosure needed for a fair presentation of these may be determined in that context. The results of operations for the three and nine-month periodsperiod ended September 30, 20182019 are not necessarily indicative of results for the entire year ending December 31, 2018.2019.

 

The accompanying consolidated financial statements have been prepared on a going concern basis which implies the Company will continue to meet its obligations for the next 12 months as of the date these financial statements are issued. 

The Company had a working capital deficit of $2,024,625 and an accumulated deficit of $36,326,324 as of September 30, 2018.  The Company also had a net loss of $4,783,640 and cash used in operating activities of $2,769,540 during the nine months ended September 30, 2018.

Management’s plan to continue as a going concern includes raising capital in the form of debt or equity, increased gross profit from revenue growth and managing and reducing operating and overhead costs.  During the second quarter of 2018, the Company engaged a nationally recognized investment bank to assist management in pursuing strategic transactions including acquisitions, dispositions, capital raising and debt restructuring. However, management cannot provide any assurances that the Company will be successful in accomplishing its plans. Management also cannot provide any assurance that unforeseen circumstances that could occur at any time within the next twelve months or thereafter will not increase the need for the Company to raise additional capital on an immediate basis. These matters, among others, raise substantial doubt about the ability of the Company to continue as a going concern. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern.

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements include the results of operations of Cake Marketing UK Ltd., or the Subsidiary. All material intercompany accounts and transactions between the Company and the Subsidiary have been eliminated in consolidation.

 

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, borrowing rate considered for operating lease right-of-use asset and related operating lease liability, and assumptions used in Black-Scholes-Merton, or BSM,Black-Scholes valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.

 


Financial Statement Reclassification

Certain account balances from prior periods have been reclassified in these unaudited condensed consolidated financial statements to conform to current period classifications. The prior year amounts have also been reclassified in these financial statements to properly report amounts under current operations and discontinued operations (see note 7).

  

Cash and Cash Equivalents

 

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less when purchased, to be cash equivalents. The Company hashad restricted cash as a result of its corporate card program through its bank. The bank, requires awhich required collateral which is placed in a money market account and can be increased or decreased at any time ataccount. The corporate card program was terminated during the discretion ofthree months ended September 30, 2019, which resulted in the Company.restricted cash balance being transferred back to the Company for its general use. The Company’s restricted cash amounted to $50,000$0 at September 30, 20182019 and $50,000 at December 31, 2017.2018. The restricted cash balance of $50,000 is included as a component of total cash and restricted cash as presented on the accompanying unaudited condensed consolidated statement of cash flows for the nine months ended September 30, 2018.

 

Accounts Receivable

 

The Company’s accounts receivableaccount receivables are due primarily from advertisers and marketers.customers relating to contracts to provide investor relation services. Collateral is currently not required. The Company also maintains allowances for doubtful accounts for estimated losses resulting from the inability of the Company’s customers to make payments. The Company periodically reviews these estimated allowances, including an analysis of the customers’ payment history and creditworthiness, the age of the trade receivable balances and current economic conditions that may affect a customer’s ability to make payments as well as historical collection trends for its customers as a whole. Based on this review, the Company specifically reserves for those accounts deemed uncollectible or likely to become uncollectible. When receivables are determined to be uncollectible, principal amounts of such receivables outstanding are deducted from the allowance.

  

September 30,

2018

  

December 31,

2017

 
         

Allowance for doubtful accounts

 $268,923  $471,144 

Long-Lived Assets

The CompanyThere was no allowance for doubtful accounts for long-lived assets in accordance with Accounting Standards Codification (“ASC”) Topic 360-10-05, “Accounting for the Impairmentas of September 30, 2019 or Disposal of Long-Lived Assets.” ASC Topic 360-10-05 requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the historical carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the carrying value of an asset by estimating the future net cash flows expected to result from the asset, including eventual disposition. If the future net cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value.December 31, 2018.

 

Concentration of Credit Risks

 

The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.

 

The Company’s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to $250,000. DuringFrom time-to-time, the nine-month period ended September 30, 2018, the Company has reachedCompany’s bank balances exceedingexceed the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits. The Company had cash balances of approximately $665,000 at September 30, 2019 that exceeded the FDIC insurance limit.

 

The Company's accounts receivable are due from customers generally located in the United States Europe, Asia, and Canada. None of the Company’sThe Company had three customers who each accounted for more than 10%13.0%, 11.7% and 11.0% of its accounts receivable at September 30, 2018 or2019 and none at December 31, 2017.  The Company does not require any collateral from its customers.2018. 

 

Revenue Recognition

 

The Company recognizes revenue on arrangements in accordance with Accounting Standards Codification, or ASC, 2014-09, Revenue from Contracts with Customers, Topic 606, the core principle of which supersedes the revenue recognition requirements in FASB ASC 605. The guidance primarily statesis that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and services. Revenue is recognized(5) recognize revenue when or as the price is fixed or determinable, persuasive evidenceCompany satisfies a performance obligation.


The Company accounts for revenues when both parties to the contract have approved the contract, the rights and obligations of an arrangement exists, the service is performed,parties are identified, payment terms are identified, and collectability of consideration is probable. Payment terms vary by client and the resulting receivable is reasonably assured.services offered.

 

ThePrior to the Company discontinuing the operations of its CAKE Business in May 2019, the Company’s SaaS revenues arewere generated from implementation and training fees and a monthly license fee, supplemented by per transaction fees paid by customers for monthly platform usage. The initial term of the customer contract iswere generally one year with one of two general cancellation policies. Each party maycould cancel the contract within the initial period or after the initial period, with 30-days’ prior notice. The Company doesdid not provide any general right of return for its delivered items. Services associated with the implementation and training fees havehad standalone value to the Company’s customers, as there are third-party vendors who offer similar services to the Company’s services. Accordingly, they qualifyqualified as separate units of accounting. The Company allocatesallocated a fair value to each element deliverable at the recognition date and recognizesrecognized such value when the services are provided. The Company bases the fair value of the implementation and training fees on third-party evidence and the monthly license fee on vendor-specific objective evidence. Fees charged by third-party vendors for implementation and training services do not vary significantly from the fees charged by the Company. Services associated with implementation and training fees arewere generally rendered within a month from the initial contract date. The value attributed to the monthly license fees as well as the fees associated with monthly transaction-based platform usage arewere recognized in the corresponding period.

 


Product Concentration

Subsequent to the closing of the Emerging Growth Agreement on June 20, 2019, the Company’s revenue is generated from the sale of promotional service packages to its customers ranging from 3 to 6 months. The Company generatesoffers different packages tailored to the type and stage of the potential customer, such as public companies looking to increase their shareholder base, as well as private companies potentially looking to go public and attract capital and publicity. The services provided by the Company include advertising, publishing of interviews and articles across its revenues from software licensing, usage,network and related transaction fees.featuring of client content on its newsletters and social media. The packages all have fixed prices that are billed monthly over the terms of the agreement in even amounts. The Company recognizes revenue for its performance obligation associated with its contracts with customers over time as work is performed, which is deemed to occur evenly throughout the duration of the contract. This also reflects the pattern in which costs are incurred on performing the contracts. To the extent revenue recognized on contracts at each period end exceeds collections, the amounts are reflected as accounts receivable. To the extent collections on contracts at each period end exceeds revenue recognized, the amounts are reflected as deferred revenue.

 

Fair Value of Financial Instruments

 

The Company accounts for assets and liabilities measured at fair value on a recurring basis in accordance with ASC Topic 820, Fair Value Measurements and Disclosures, or ASC 820. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, establishes a framework for measuring fair value, and expands disclosure about such fair value measurements.

 

ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:

 

Level 1:

Observable inputs such as quoted market prices in active markets for identical assets or liabilities.

  

Level 2:

Observable market-based inputs or unobservable inputs that are corroborated by market data.

  

Level 3:

Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.


 

Additional Disclosures Regarding Fair Value Measurements

 

The carrying value of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, and lines of credit approximate their fair value due to the short-term maturity of these items.

 

Advertising

 

The Company expenses advertising costs as incurred. Advertising expenses relating to continuing operations amounted to $148,738 and $160,029 for the three and nine months ended September 30, 2019, respectively. There were no advertising expenses during 2018 relating to continuing operations. Advertising expenses reported as a component of discontinued operations amounted to $0 and $140,907 for the three months ended September 30, 2019 and 2018, respectively, and $159,665 and $415,358 for the nine months ended September 30, 2019 and 2018, respectively.

  

Three months ended

  

Nine months ended

 
  

September 30,

  

September 30,

 
  

2018

  

2017

  

2018

  

2017

 

Advertising expense

 $140,907  $84,302  $415,358  $254,446 

 

Income Taxes

 

Income taxes are accounted for in accordance with the provisions of ASC Topic 740, Accounting for Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts expected to be realized, but no less than quarterly.

 

Foreign Currency Translation

 

The Company’s reporting currency is U.S. Dollars. The functional currency of the Company’s Subsidiary in the United Kingdom iswas British Pounds. The translation from British Pounds to U.S. dollars is performed for asset and liability accounts using exchange rates in effect at the balance sheet date, equity accounts using historical exchange rates or rates in effect at the balance sheet date, and for revenue and expense accounts using the average exchange rate in effect during the period. The resulting translation adjustments are recorded as a component of Accumulated Other Comprehensive Income (Loss). Foreign currency translation gains and losses arising from exchange rate fluctuation on transactions denominated in a currency other than the functional currency are included in the consolidated statements of operations.

 


Software Development Costs

 

At December 31, 2018, the Company impaired the entire balance of unamortized internal-use software development costs which amounted to approximately $4,725,000 and did not capitalize internal-use software development costs in 2019. Costs incurred in the research and development of software products and significant upgrades and enhancements thereto during the preliminary project stage and the post-implementation operation stage are expensed as incurred. Costs incurred for maintenance and relatively minor upgrades and enhancements are expensed as incurred. CostsPrior to the December 31, 2018 impairment, costs associated with the application development stage of new software products and significant upgrades and enhancements thereto arewere capitalized when 1) management implicitly or explicitly authorizesauthorized and commitscommitted to funding a software project and 2) it iswas probable that the project willwould be completed and the software willwould be used to perform the function intended. The Company capitalized internal-use software development costs of $375,000 and $1,125,000 during the nine monthsthree and nine-month periods ended September 30, 2018. The Company amortizesamortized such costs once the new software products and significant upgrades and enhancements arewere completed. The unamortized internal-use software development costs amounted to $4,624,377 and $3,925,523 at September 30, 2018 and December 31, 2017, respectively. The Company’s amortization expenses associated with capitalized software development costs amounted to $105,000 and $426,146 during the three and nine-month periods ended September 30, 2018 respectively, and $193,935 and $509,039was reflected in cost of revenues. There were no expenses associated with capitalized software development costs during the three and nine-month periods ended September 30, 2017, respectively. Amortization2019. The amortization expenses above are reported as a component of internal-use softwarediscontinued operations.


Property and Equipment

Property and equipment are recorded at cost and are depreciated on a straight-line basis over their estimated useful lives of five years. Maintenance and repairs are charged to expense as incurred. Significant renewals and betterments are capitalized. 

Goodwill

The Company’s goodwill represents the excess of purchase price over tangible and intangible assets acquired, less liabilities assumed arising from business acquisitions. Goodwill is reflectednot amortized, but is reviewed for potential impairment on an annual basis at the reporting unit level. There was no impairment recorded during the three and nine months ended September 30, 2019 or 2018.

Long-Lived Assets

In accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in costcircumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of revenues.assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. There was no impairment of long-lived assets identified during the three and nine months ended September 30, 2019 or 2018.

Basic and Diluted Earnings Per Share

Basic earnings per share are calculated by dividing income available to stockholders by the weighted-average number of common shares outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common share equivalents outstanding during the period. Dilutive common share equivalents consist of shares issuable upon the exercise of stock options and warrants (calculated using the modified-treasury stock method). As of September 30, 2019, the Company had 6,595,000 outstanding stock options and 8,127,184 outstanding warrants which were excluded from the calculation of diluted earnings per share because their effects were anti-dilutive. As of September 30, 2018, the Company had 7,237,500 outstanding stock options and 25,045,517 outstanding warrants which were excluded from the calculation of diluted earnings per share because their effects were anti-dilutive. As a result, the basic and diluted earnings per share are the same for each of the periods presented.

 

Share-Based Payment

 

The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation-Stock Compensation, or ASC 718. Under the fair value recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.

 

The Company has elected to use the BSMBlack-Scholes option-pricing model to estimate the fair value of its options, which incorporates various subjective assumptions including volatility, risk-free interest rate, expected life, and dividend yield to calculate the fair value of stock option awards. Compensation expense recognized in the statements of operations is based on awards ultimately expected to vest and reflects estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

 

Common stock awards

 

The Company has granted common stock awards to non-employees in exchange for services provided. The Company measures the fair value of these awards using the fair value of the services provided or the fair value of the awards granted, whichever is more reliably measurable. The fair value measurement date of these awards is generally the date the performance of services is complete.granted. The fair value of the awards is recognized on a straight-line basis as services are rendered. The share-based payments related to common stock awards for the settlement of services provided by non-employees is recorded on the consolidated statement of comprehensive loss in the same manner and charged to the same account as if such settlements had been made in cash.


 

Warrants

 

In connection with certain financing, consulting and collaboration arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded at fair value as a reduction in additional paid-in capital of the common stock issued. All other warrants are recorded at fair value as expense over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 6, Stockholders’ Equity.  

Segment Reporting

The Company generated revenues from one source, its SaaS business, during the three and nine-month periods ended September 30, 2018 and 2017. The Company's chief operating decision maker evaluates the performance of the Company based upon revenues and expenses by functional areas as disclosed in the Company's statements of operations.Deficit.  

  

Recent Accounting Pronouncements

In February 2016, the FASB issued ASU 2016-02, “Leases” (Topic 842).  This guidance will be effective for public entities for fiscal years beginning after December 15, 2018 including the interim periods within those fiscal years. Early application is permitted. Under the new provisions, all lessees will report a right-of-use asset and a liability for the obligation to make payments for all leases with the exception of those leases with a term of 12 months or less.  All other leases will fall into one of two categories: (i) Financing leases, similar to capital leases, which will require the recognition of an asset and liability, measured at the present value of the lease payments and (ii) Operating leases which will require the recognition of an asset and liability measured at the present value of the lease payments. The Company has adopted this standard on January 1, 2019 and recognized assets and liabilities arising from any leases that meet the requirements under this standard on the adoption date and included qualitative and quantitative disclosures in the Company’s notes to the condensed consolidated financial statements.

 

In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350), which simplifies the goodwill impairment test. The effective date for ASU 2017-04 is for fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. TheThis Company is currently evaluatingassessing the impact of the new guidance on its financial statements.

In July 2018, the FASB issued ASU 2018-09 to provide clarification and correction of errors to the Codification. The amendments in this update cover multiple Accounting Standards Updates. Some topics in the update may require transition guidance with effective dates for annual periods beginning after December 15, 2018. The Company is currently evaluating the impact of the new guidancestandard on its financial statements.

 

In January 2016, the FASB issued ASU No. 2016‑01,2016-01, Financial Instruments — Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. The guidance affects the accounting for equity investments, financial liabilities under the fair value option and the presentation and disclosure requirements of financial instruments. The guidance is effective in the first quarter of fiscal 2019. Early adoption is permitted for the accounting guidance on financial liabilities under the fair value option. The Company is currently evaluating the impact of the new guidance on its financial statements.


In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) and subsequently amended the guidance relating largely to transition considerations under the standard in January 2017. The objective of this update is to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those annual periods and is to be applied utilizing a modified retrospective approach. The Company is currently evaluating the impact of the new guidance on its financial statements.

In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. This new standard clarifies the definition of a business and provides a screen to determine when an integrated set of assets and activities is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. Since the Company has not acquired any material businesses, this standard has no impact on itsthe Company’s financial statements.

 

In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash. The objective of this ASUstandard is to eliminate the diversity in practice related to the classification of restricted cash or restricted cash equivalents in the statement of cash flows. For public business entities, this ASUstandard is effective for annual and interim reporting periods beginning after December 15, 2017. The Company has adopted this standard on January 1, 2018, and it has had no material impact on its financial statements.

 

In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting (ASU 2016-09), which provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. This pronouncement is effective for annual reporting periods beginning after December 15, 2017. The Company has adopted this standard on January 1, 2018 and it has had no material impact on its financial statements.

 

In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, to expand the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees and supersedes the guidance in Subtopic 505-50, Equity - Equity-Based Payments to Non-Employees. Under ASU 2018-07, equity-classified nonemployee share-based payment awards are measured at the grant date fair value on the grant date. The probability of satisfying performance conditions must be considered for equity-classified nonemployee share-based payment awards with such conditions. This Company has adopted this standard on January 1, 2019 and it has had no impact in the Company’s condensed consolidated financial statements.

Other accounting pronouncements have been issued but deemed by management to be outside the scope of relevance to the Company. 

 


Basic and Diluted Earnings Per Share

NOTE 3: PROPERTY AND EQUIPMENT

 

Basic earnings per share are calculated by dividing income availableThe Company’s property and equipment relating to stockholders bycontinuing operations consisted of the weighted-average number of common shares outstanding during each period. Diluted earnings per share are computed using the weighted average number of commonfollowing at September 30, 2019 and dilutive common share equivalents outstanding during the period. Dilutive common share equivalents consist of shares issuable upon the exercise of stock options and warrants (calculated using the modified-treasury stock method).December 31, 2018.

 

  

Three months ended

September 30

  

Nine months ended

September 30

 
  

2018

  

2017

  

2018

  

2017

 

Numerator:

                

Net loss

 $(1,963,137

)

 $(695,745

)

 $(4,783,640

)

 $(1,367,678

)

                 

Denominator:

                

Denominator for basic earnings per share--weighted average shares

  66,177,101   65,520,434   66,019,709   65,356,201 

Effect of dilutive securities- when applicable:

                

Stock options

  -   -   -   - 

Warrants

  -   -   -   - 

Denominator for diluted earnings per share--adjusted weighted-average shares and assumed conversions

  66,177,101   65,520,434   66,019,709   65,356,201 
                 

Loss per share:

                

Basic

 $(0.03

)

 $(0.01

)

 $(0.07

)

 $(0.02

)

Diluted

 $(0.03

)

 $(0.01

)

 $(0.07

)

 $(0.02

)

                 

Weighted-average anti-dilutive common share equivalents

  29,229,427   17,091,949   26,043,047   16,579,396 
  

September 30,

  

December 31,

 
  

2019

  

2018

 
  

(Unaudited)

     
         

Computer equipment and software

 $8,139  $- 
         
   8,139   - 
         

Less: accumulated depreciation

  (4,770)  - 
         
  $3,369  $- 

Depreciation expense from continuing operations for the three and nine months ended September 30, 2019 amounted to $368 and $565, respectively. There was no depreciation expense from continuing operations during 2018.  

NOTE 4: ACQUISITONS

On May 15, 2019, the Company entered into the Emerging Growth Agreement with Emerging Growth, LLC (see Note 1), which closed on June 20, 2019. Pursuant to the terms of the Emerging Growth Agreement, the Company acquired certain assets from the Seller related to its sponsored content and marketing business for a purchase price consideration consisting of $420,000 in cash, 30,000,000 shares of the Company’s common stock valued at $2,700,000, and 3,000 shares of Series B preferred stock valued at $687,000. As a result, the total purchase price amounted to $3,807,000.

A summary of the purchase price allocation at fair value is below.  The business combination accounting is not yet complete and the amounts assigned to the net assets acquired are provisional.  Therefore, this may result in future adjustments to the provisional amounts as new information is obtained about facts and circumstances that existed at the acquisition date.

  

Purchase

Allocation

 

Property and equipment

 $2,183 

Other intangible assets

  579,000 

Goodwill

  3,225,817 
  $3,807,000 

 


 

PropertyIntangible assets acquired represent amounts allocated to customers contracts of $7,000 and Equipment and Intangible Assets

Property and equipment are recorded at cost and are depreciated on a straight-line basis over their estimated useful lives of three years. Maintenance and repairs are charged to expense as incurred. Significant renewals and betterments are capitalized.

Property and equipment andmarketing-related intangible assets consist of $572,000, for an aggregate total of $579,000. The intangible assets related to customer contracts are being amortized over a period of approximately 5 months and the following at:

  

September 30,

2018

  

December 31,

2017

 

Computer equipment and software

 $437,302  $431,497 

Office furniture and equipment

  124,900   120,420 

Leasehold improvements

  290,360   292,640 

Total (1)

  852,562   844,557 

Accumulated depreciation (2)

  (788,587

)

  (775,152

)

Total

 $63,975  $69,405 

(1) Includes 6,150 in foreign exchange translation

        

(2) Includes (3,085) in foreign exchange translation

        
         

Intangible assets

 $7,562,727  $6,437,726 

Accumulated amortization

  (2,938,350

)

  (2,512,203

)

Total

 $4,624,377  $3,925,523 

  

Three months ended

  

Nine months ended

 
  

September 30,

  

September 30,

 
  

2018

  

2017

  

2018

  

2017

 
                 

Depreciation expense

 $10,035  $34,071  $35,747  $103,601 

Amortization expense on intangible assets

 $105,000  $193,935  $426,146  $509,038 

Duringmarketing-related intangible assets are being amortized over 10 years. Amortization expense for intangible assets for both the three and nine-month periodsnine months ended September 30, 2018, the Company disposed2019 amounted to $20,525. Estimated future amortization of approximately $19,000 mostly in computer equipment with a net book valueintangible assets as of approximately $2,000 for proceeds of $750.September 30, 2019 is as follows.

  

Year Ended

 
  

December 31,

 

2019 (remainder of)

 $16,751 

2020

  57,200 

2021

  57,200 

2022

  57,200 

2023

  57,200 

Thereafter

  312,924 

Total

 $558,475 

 

DuringThe following are the unaudited pro forma results of operations for the three and nine-month periodsnine months ended September 30, 2017,2019 and 2018, as if the Company disposedassets purchased in the Emerging Growth Agreement had been acquired on January 1, 2018.  The pro forma results include estimates and assumptions which management believes are reasonable.  However, pro forma results do include any anticipated cost savings or other effects of approximately $0the planned integration of these entities, and $7,500are not necessarily indicative of the results that would have occurred if the business combination had been in computer equipment with a net book value of approximately $0 and $1,700 for proceeds of approximately $0 and $800, respectively.effect on the dates indicated.

  

Pro Forma Combined Financials (Unaudited)

 
  

Nine Months Ended

September 30, 2019

  

Nine Months Ended

September 30, 2018

 
         

Revenue from continuing operations

 $1,687,555  $1,552,730 
         

Net loss from continuing operations

 $(1,160,045) $(575,749)
         

Net loss from continuing operations per common share - basic and diluted

 $(0.01) $(0.01)

 

NOTE 3: PREPAID EXPENSES

At September 30, 2018 and December 31, 2017, the Company’s prepaid expenses consisted primarily of prepaid insurance and tradeshow costs.

NOTE 4: DEFERRED REVENUES

The Company’s deferred revenues consist of prepayments made by certain of the Company’s customers and undelivered implementation and training fees.  The Company decreases the deferred revenues by the amount of the services it renders to such customers when provided. 

  

September 30,

2018

  

December 31,

2017

 
         

Deferred revenues

 $564,002  $299,937 
  

Pro Forma Combined Financials (Unaudited)

 
  

Thee Months Ended

September 30, 2019

  

Thee Months Ended

September 30, 2018

 
         

Revenue from continuing operations

 $568,992  $545,582 
         

Net loss from continuing operations

 $(415,443) $(247,501)
         

Net loss from continuing operations per common share - basic and diluted

 $(0.00) $(0.00)

 


 

NOTE 5: CREDIT FACILITY AND LOANSNOTE PAYABLE

Agility Loan

  

September 30,

2018

  

December 31,

2017

 

Agility Loan

 $625,000  $625,000 

Amendment, added to balance

  400,000   400,000 

Principal Payment of Agility Loan

  (450,000

)

  (425,000

)

Less: Loan repayment

  (575,000

)

  - 
Balance $-  $600,000 

 

On March 11, 2016,September 10, 2019, the Company entered into a subordinated loan, orpromissory note payable whereby the Agility Loan, with Agility Capital II, LLC, or Agility Capital, which provides for total availability of $625,000 and was to originally mature, prior to amendment,Company borrowed $500,000 bearing interest at 8% per annum. Interest on March 31, 2017. The Agility Loan has a fixed interest rate of 12% per year and requires $25,000 monthly amortization payments beginningthe note is payable quarterly on June 1, 2016. The Agility Loan also requires fees of approximately $130,000 over the life of the loan and is subject to a total aggregate minimum interest of $50,000 in the event of a prepayment. The Agility Loan contains covenants to achieve specified Adjusted EBITDA levels, as defined, limiting capital expenditures, restricting the Company’s ability to pay dividends, purchase and sell assets outside the ordinary course and incur additional indebtedness. Asfirst business day of December, 31, 2017,March, June and at repaymentSeptember commencing December 1, 2019. Outstanding principal on the note is due in full on September 30, 2022.

Future scheduled maturities of the Agility Loan, the Company was in compliance with these covenants. The Agility Loan requires a security interest in all of the Company’s personal property and intellectual property, second in priority to SaaS Capital Funding II, LLC.long-term debt are as follows.

  

Year Ended

 
  

December 31,

 
     

2019 (remainder of)

 $- 

2020

  - 

2021

  - 

2022

  500,000 

Total

 $500,000 

 

In connection with the Agility Loan,promissory note payable on June 30, 2016, as a result of outstanding amounts under the Agility Loan,September 10, 2019, the Company issued to Agility Capital a warrant to purchase up to 69,444 shares of the Company’s Common Stock at an exercise price of $0.45 per share. This warrant expires on March 11, 2021. The fair value of the warrant amounted to $15,880 and was capitalized as deferred financing costs, of which $0 and $3,970 was expensed during the three and nine-month periods ended September 30, 2017, respectively, and $0 was expensed during 2018.

On November 29, 2016, the Company entered into an amendment of the Agility Loan which waived any event of default and the breach of any covenant, representation, warranty, and any other agreement contained in the Agility Loan as a result of the Company entering into a settlement agreement with respect to pending litigation between the Company and a former officer during November 2016, or the Settlement Agreement. On the date of the amendment, a loan modification fee in the amount of $100,000, fully earned and non-refundable, was added to the outstanding loan balance. Additionally, the maturity date was extended to December 31, 2017. On November 29, 2016, the Company issued to Agility Capital a warrant to purchase up to 187,500 shares of the Company’s Common Stock at an exercise price of $0.40 per share. This warrant expires on November 29, 2021. The fair value of the warrant amounted to $42,427 and was capitalized as deferred financing costs, of which $9,791 and $29,372 was expensed during the three and nine-month periods ended September 30, 2017, respectively, and $0 was expensed during 2018.

On August 14, 2017, the Company entered into a consent to waiver of the Agility Loan, to permit the issuance of promissory notes to lenders, as further described below.

On November 8, 2017, the Company entered into the third amendment of the Agility Loan, or the Third Amendment, whereby Agility Capital agreed to loan an additional $300,000 to the Company, such that the aggregate principal amount owing to Agility Capital as of November 9, 2017 was $625,000. The Third Amendment extended the maturity date of the Agility Loan from December 31, 2017 to December 31, 2018. A loan modification fee of $125,000 was deducted from the Additional Loan amount. This arrangement was treated as a substantial modification of existing debt pursuant to the guidance of ASC 470-50 “Debt – Modifications and Extinguishments” (“ASC 470-50”). Because the net present value of the modified notes was greater than 10% of the present value of the remaining cash flows under the old debt, the transaction was treated as a debt extinguishment and reissuance of a new debt instrument, with the fair value of $606,034 and therefore recorded $106,034 as a loss on debt extinguishment.  The carrying value of the $625,000 did not change as a result of the extinguishment since the discounts recognized at inception of these new notes were fully amortized at the time of the issuance. 

On January 26, 2018, the Company repaid the Agility Loan by paying Agility Capital approximately $581,000 which terminated the loan agreement between the Company and Agility Capital and released Agility Capital’s security interest in Company assets. The Company owed $0 and $600,000 under the Agility Loan at September 30, 2018 and December 31, 2017, respectively.

Credit Facility - SaaS Capital Loan

  

September 30,

2018

  

December 31,

2017

 

SaaS Capital Loan, Total advances

 $10,253,000  $9,903,000 

Principal Payment of SaaS Capital Loan

  (4,601,269

)

  (2,198,616

)

Less: Deferred financing cost

  (151,649

)

  (245,584

)

Less: SaaS Capital Loan, short term

  (3,501,487

)

  (3,055,812

)

SaaS Capital Loan, long term

 $1,998,595  $4,402,988 


On May 5, 2016, the Company entered into a loan and security agreement, or the SaaS Capital Loan, with SaaS Capital Funding II, LLC to borrow up to a maximum of $8,000,000. Initial amounts borrowed will accrue interest at the rate of 10.25% per annum with future amounts borrowed bearing interest at the greater of 10.25% or 9.21% plus the three-year treasury rate at the time of advance. Accrued interest on amounts borrowed is payable monthly for the first six months and thereafter 36 equal monthly payments of principal and interest is payable. Prepayments will be subject to a 10%, 6% or 3% of principal premium if prepaid prior to 12 months, between 12 and 24 months, or between 24 months and maturity, respectively. Advances may be requested until May 5, 2018. The initial minimum advance amount of $5,000,000, on May 5, 2016, was used to repay the outstanding line of credit balance of $4,572,223. A facility fee of $80,000 was paid by the Company in connection with the initial advance and an additional $80,000 was paid on May 5, 2017. Additionally, the Company incurred initial financing costs of $160,000 which was capitalized as deferred financing costs, of which $13,333 and $40,000 was expensed during the three and nine-month periods ended September 30, 2018 and 2017, respectively.

The SaaS Capital Loan contains customary covenants including, but not limited to, covenants to achieve specified Adjusted EBITDA levels and revenue renewal levels, limiting capital expenditures and restricting the Company's ability to pay dividends, purchase and sell assets outside the ordinary course and incur additional indebtedness. As of September 30, 2018, the Company was in compliance with such covenants. The occurrence of a material adverse change will be an event of default under the SaaS Capital Loan, in addition to other customary events of default. The Company granted SaaS Capital Funding II, LLC a security interest in all of the Company's personal property and intellectual property through the SaaS Capital Loan and the Patent, Trademark and Copyright Security Agreement between the Company and SaaS Capital Funding II, LLC.

On May 5, 2016, in connection with the SaaS Capital Loan, the Company issued to SaaS Capital Partners II, LP, an affiliate of SaaS Capital Funding II, LLC, a warrant to purchase up to 1,333,333 shares of the Company's common stock at an exercise price of $0.45 per share subject to certain adjustments for dividends, splits or reclassifications. The Warrant is exercisable until the earlier of May 5, 2026, or the date that is 5 years from the date the Company’s equity securities are first listed for trading on NASDAQ. The Company paid approximately $169,000 in financing costs through September 30, 2016. The fair value of the warrant amounted to $383,128 and was capitalized as deferred financing costs, of which $31,927 and $95,781 was expensed during the three and nine-month periods ended September 30, 2018 and 2017, respectively.

On November 29, 2016, the Company entered into an amendment of the SaaS Capital Loan to receive consent from SaaS Capital to enter into the Settlement Agreement. The amendment required a loan modification fee of $120,000, payable at $10,000 a month for one year, expensed in the statement of operations. In connection with this amendment, the Company agreed to issue SaaS Capital a warrant to purchase up to 200,000 shares of our Common Stock at an exercise price of $0.36 per share. This warrant expires on November 29, 2026. The fair value of the warrant amounted to $60,185 which was fully expensed at December 31, 2016.

On May 10, 2017, the Company entered into a second amendment of the SaaS Capital Loan which adjusted the Minimum Adjusted EBITDA covenant of the SaaS Capital Loan from $0 to ($150,000) until August 31, 2017 to give the Company added flexibility in completing its hosting migration to a new platform and to allow for potentially augmented marketing and sales efforts.

On June 16, 2017, the Company entered into a third amendment of the SaaS Capital Loan to provide that any advance made within 6 months of the final advance date will be for a 36-month period with interest only payments due from the date of advance until the final advance date.

On August 14, 2017, the Company entered into a fourth amendment of the SaaS Capital Loan to permit the issuance of promissory notes to lenders, further described below.

On November 8, 2017, the Company entered into a fifth amendment, or the Fifth Amendment, of the SaaS Capital Loan which adjusted the Minimum Adjusted EBITDA covenant of the SaaS Capital Loan from $0 to ($170,000) until October 31, 2017, to ($150,000) from November 1, 2017 to December 31, 2017, to ($100,000) from January 1, 2018 to May 31, 2018, to ($50,000) from June 1, 2018 to August 31, 2018, and to $0 thereafter. The Fifth Amendment added a new minimum liquidity covenant for a cash balance of $600,000 effective January 31, 2018. The Fifth Amendment also memorialized SaaS Capital’s waiver of the Minimum Adjusted EBITDA covenant for September 2017. In connection with the Fifth Amendment, the Company agreed to pay to SaaS Capital a fee of $375,000 upon the payment in full of all outstanding advances. 

On January 25, 2018, the Company entered into a sixth amendment, or the Sixth Amendment, of the SaaS Capital Loan to permit the Company to enter into the Beedie Credit Agreement, further described below, and to permit the repayment of Agility Capital and of the promissory notes to lenders, further described below. The Sixth Amendment also amended the Company’s adjusted EBITDA covenant and added covenants requiring a minimum gross margin and specified debt to monthly recurring revenue ratios. This arrangement was treated as a normal modification of existing debt pursuant to the guidance of ASC 470-50 “Debt – Modifications and Extinguishments” (“ASC 470-50”). Because the net present value of the modified notes was lesser than 10% of the present value of the remaining cash flows under the old debt, the transaction was treated as a debt modification. In connection with the Sixth Amendment, the Company agreed to issue SaaS Capital a warrant to purchase up to 200,000 shares of its Common Stock at an exercise price of $0.35 per share, subject to certain adjustments for dividends, splits or reclassifications. The fair value of the warrant amounted to $56,834 and was capitalized as deferred financing costs, of which $4,736 and $12,629 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.


On May 31, 2018, the Company entered into a seventh amendment, or the Seventh Amendment, of the SaaS Capital Loan to permit the issuance of promissory notes to lenders, as further described below, to amend the Company’s adjusted EBITDA, revenue renewal and total debt to monthly recurring revenue covenants, to increase the success fee payable upon repayment of the facility by $120,000 to $495,000, and to fix prepayment penalties until October 31, 2018.

On June 13, 2018, the Company entered into an eighth amendment, or the Eighth Amendment, of the SaaS Capital Loan with SaaS Capital, to issue additional promissory notes, as further described below.

On August 31, 2018, the Company entered into a ninth amendment, or the Ninth Amendment, of the SaaS Capital Loan with SaaS Capital, to permit the issuance of promissory notes to lenders, as further described below, to amend the Company’s minimum adjusted EBITDA, revenue renewal, total debt to monthly recurring revenue and secured debt to monthly recurring revenue covenants, to increase the success fee payable upon repayment of the facility to $555,000 and to provide for twice monthly reporting of the Company’s projected cash flows.

During the nine-month period ended September 30, 2018, the Company borrowed $350,000 from the SaaS Capital Loan, and made principal payments of $2,402,653.

The Company owed $5,651,731 and $7,704,384 under the SaaS Capital Loan at September 30, 2018 and December 31, 2017, respectively.

2017 Promissory Notes

  

September 30,

2018

  

December 31,

2017

 

Promissory Notes, Total

 $1,000,000  $1,000,000 

Principal Payment of Promissory Notes

  (1,000,000

)

  - 

Promissory Notes, Outstanding balance

  -   1,000,000 

Less: Deferred Financing cost

  -   (82,868

)

Less: Promissory Notes, short term

  -   (649,194

)

Balance

 $-  $267,938 

On August 14, 2017, the Company borrowed an aggregate of $1,000,000 from seven lenders, or the 2017 Lenders, and issued promissory notes, or the 2017 Promissory Notes, for the repayment of the amounts borrowed. The 2017 Lenders are all accredited investors, certain of the 2017 Lenders are shareholders of the Company, one of the 2017 Lenders is an affiliate of the Company’s director, Greg Akselrud, and two of the 2017 Lenders are each affiliated with a partner of Mr. Akselrud’s in the law firm of Stubbs Alderton and Markiles, LLP. The 2017 Promissory Notes are unsecured, have a maturity date of August 14, 2019 and all principal is due upon maturity. Amounts borrowed accrue interest at 12% per annum and accrued interest is payable monthly. The Company also issued to the 2017 Lenders three-year warrants to purchase an aggregate of 1,000,000 shares of the Company’s Common Stock at an exercise price of $0.35 per share. The fair value of the warrant amounted to $104,676 and was capitalized as deferred financing costs, of which $0 and $82,868 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $8,723 and $8,723 was expensed during the three and nine-month periods ended September 30, 2017.

On January 26, 2018, the Company paid approximately $1,074,000 to repay the 2017 Promissory Notes which includes approximately $65,000 in additional interest expenses due to the repayment date which was prior to the maturity date. The Company owed $0 and $1,000,000 under the 2017 Promissory Notes at September 30, 2018 and December 31, 2017, respectively.

Beedie Credit Agreement

  

September 30,

2018

  

December 31,

2017

 

Total advances

 $6,000,000  $- 

Principal Payment of Loan

  -   - 

Less: Deferred financing cost

  (1,593,841

)

  - 

Balance

 $4,406,159  $- 


On January 25, 2018, the Company entered into a non-revolving term credit agreement, or the Beedie Credit Agreement, with Beedie Investments Limited, or Beedie, to borrow up to a maximum of $7,000,000. Outstanding principal will accrue interest at the rate of 12% per annum increasing to 14% per annum if the Company’s gross margins fall below amounts specified in the Beedie Credit Agreement. Accrued interest on outstanding principal is payable monthly in arrears. The Company paid Beedie a commitment fee of $175,000 and will pay to Beedie a monthly standby fee of 0.325% on the unadvanced and available amount. Advances may be requested until July 25, 2020 and outstanding principal must be paid in full on January 25, 2021. Prepayment, which if at the Company’s option must be made in full and is otherwise required following certain asset dispositions, will be subject to a fee of 24 months accrued interest less all interest previously paid by the Company on the outstanding principal amount if paid prior to January 25, 2020. The initial minimum advance amount of $4,500,000 was advanced on January 26, 2018. Approximately $581,000 of the initial advance was used to repay Agility Capital to terminate the loan agreement between the Company and Agility dated March 11, 2016, as amended, and to release Agility Capital’s security interest in Company assets. Approximately $1,074,000 of the initial advance was used to repay the 2017 Promissory Notes. The $175,000 commitment fee was capitalized as deferred financing costs, of which $14,583 and $38,888 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.

The Beedie Credit Agreement contains customary covenants including, but not limited to, covenants to achieve specified adjusted EBITDA levels, to maintain minimum revenue renewal and liquidity levels, to maintain minimum gross margins, to maintain specified debt to monthly recurring revenue ratios, that limit capital expenditures and restrict the Company's ability to pay dividends, purchase and sell assets outside the ordinary course, and that limit the Company’s ability to incur additional indebtedness. As of September 30, 2018, the Company was in compliance with such covenants. The occurrence of a material adverse change will be an event of default under the Beedie Credit Agreement, in addition to other customary events of default. Default interest will be charged at 18% per annum. The Company granted Beedie a security interest, subordinated to the security interest of SaaS Capital, in all of the Company's assets through a pledge and security agreement, patent security agreement and trademark security agreement, each between the Company and Beedie. As additional security, the Company’s Subsidiary issued an unlimited guarantee to Beedie. Beedie is entitled to board of director observation rights during the term of the Beedie Credit Agreement. 

In connection with the Beedie Credit Agreement, the Company issued to Beedie a warrant, or the Beedie Warrant, to purchase up to 4,500,000 shares of the Company's common stock at an exercise price of $0.35 per share subject to certain adjustments for dividends, splits or reclassifications, and a weighted average adjustment for certain issuances of common stock below the exercise price prior to January 26, 2019. Up to 2,500,000 additional shares of common stock under the Beedie Warrant will be exercisable on a pro rata basis to additional amounts borrowed if and when advanced under the Beedie Credit Agreement. The Company adopted ASU 2017-11 which revises ASC 815-10-15-74 to allow instruments with a down round feature to qualify for equity classification. Under the new guidance, the issuer would recognize the value of the feature only when it is activated and there is an actual reduction of the strike price or conversion feature.  The value of the adjustment is then to be recorded as deemed dividend and a reduction of income available to common stockholders. The fair value of the warrant amounted to $1,099,861 and was capitalized as deferred financing costs, of which $91,655 and $244,413 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.

On May 31, 2018, the Company entered into a first amendment, or the First Beedie Amendment, of the Beedie Credit Agreement to permit the issuance of additional promissory notes to lenders, as further described below, to amend the Company’s adjusted EBITDA, revenue renewal and total debt to monthly recurring revenue covenants, and to add a secured debt to monthly recurring revenue covenant. In addition, the Company issued to Beedie a warrant to purchase up to 500,000 shares of the Company's common stock at an exercise price of $0.35 per share subject to certain adjustments for dividends, splits or reclassifications, and a weighted average adjustment for certain issuances of common stock below the exercise price prior to January 25, 2019. This arrangement was treated as a normal modification of existing debt pursuant to the guidance of ASC 470-50 “Debt – Modifications and Extinguishments” (ASC 470-50). Because the net present value of the modified notes was lesser than 10% of the present value of the remaining cash flows under the old debt, the transaction was treated as a debt modification. The fair value of the warrant amounted to $120,330 and was capitalized as deferred financing costs, of which $10,027 and $13,370 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.

On June 13, 2018, the Company entered into a second amendment, or the Second Beedie Amendment, of the Beedie Credit Agreement to issue additional promissory notes, as further described below. In addition, the Company issued to Beedie a warrant to purchase up to 100,000 shares of the Company's common stock at an exercise price of $0.35 per share subject to certain adjustments for dividends, splits or reclassifications, and a weighted average adjustment for certain issuances of common stock below the exercise price prior to January 25, 2019. This arrangement was treated as a normal modification of existing debt pursuant to the guidance of ASC 470-50 “Debt – Modifications and Extinguishments” (ASC 470-50). Because the net present value of the modified notes was lesser than 10% of the present value of the remaining cash flows under the old debt, the transaction was treated as a debt modification. The fair value of the warrant amounted to $24,053 and was capitalized as deferred financing costs, of which $2,004 and $2,672 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.

On August 31, 2018, the Company entered into a third amendment, or the Third Beedie Amendment, of the Beedie Credit Agreement to borrow the second tranche of the term loan facility in the amount of $1,500,000, to permit the issuance of additional promissory notes to lenders, as further described below, to amend the commitment fee, to amend the Company’s minimum adjusted EBITDA, revenue renewal, total debt to monthly recurring revenue and secured debt to monthly recurring revenue covenants and to provide for twice monthly reporting of the Company’s projected cash flows. In connection with the Third Beedie Amendment, the Company issued to Beedie a warrant to purchase up to 1,500,000 shares of the Company's common stock and a warrant to purchase up to an additional 835,000 shares of the Company’s common stock at an exercise price of $0.35$0.10 per share subject to certain adjustments for dividends, splits or reclassifications,share. The warrants expire on September 10, 2024 and a weighted average adjustment for certain issuancesare fully vested upon issuance. The note was discounted by $17,624 allocated from the valuation of common stock below the exercise price prior to January 25, 2019.warrants issued. The fair value of these warrantsdiscount recorded on the note is being amortized as interest expense through the maturity date, which amounted to $412,484 and was capitalized as deferred financing costs, of which $11,458 and $11,458 was expensed during$322 for the three and nine-month periodsnine months ended September 30, 2018, respectively, and $0 during 2017.


2018 Promissory Notes

  

September 30,

2018

  

December 31,

2017

 

Promissory Notes, Total

 $2,000,000  $- 

Principal Payment of Promissory Notes

  -   - 

Promissory Notes, Outstanding Balance

  2,000,000   - 

Less: Deferred Financing Cost

  (655,305

)

  - 

Less: Related Party Portion

  (550,000

)

    

Balance

 $794,695  $- 

On May 31, 2018, and June 15, 2018,2019. As of September 30, 2019, the Company borrowed an aggregate of $1,500,000 and $500,000, respectively, from thirteen lenders, or the 2018 Lenders, and issued promissory notes, or the 2018 Promissory Notes, for the repayment of the amounts borrowed. The 2018 Lenders are all accredited investors, one of the 2018 Lenders is an affiliate of the Company’s director, Greg Akselrud, one of the 2018 Lenders is an affiliate of the Company’s Chief Financial Officer, Anthony Mazzarella, two of the 2018 Lenders are related to the Company’s Chairman and Chief Executive Officer, Brian Ross, and two of the 2018 Lenders are employees of the Company. The 2018 Promissory Notes are unsecured, have a maturity date of May 30, 2021 and all principal is due upon maturity. Amounts borrowed accrue interest at 12% per annum and accrued interest is payable monthly. The Company also issued to the 2018 Lenders six-year warrants to purchase an aggregate of 3,000,000 shares of the Company’s Common Stock at an exercise price of $0.35 per share. The fairnet book value of the warrantspromissory note amounted to $737,218 and was capitalized as deferred financing costs,$482,698 including the principal amount outstanding of which $61,435 and $81,913 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.

August 2018 Promissory Notes

  

September 30,

2018

  

December 31,

2017

 

Promissory Notes, Total

 $1,500,000  $- 

Principal Payment of Promissory Notes

  -   - 

Promissory Notes, Outstanding balance

  1,500,000   - 

Less: Deferred financing cost

  (269,109

)

  - 
Balance  $1,230,891  $- 

On August 31, 2018, the Company borrowed an aggregate of $1,500,000 from ten lenders, or the August 2018 Lenders, and issued promissory notes, or the August 2018 Promissory Notes, for the repayment$500,000 net of the amounts borrowed. The August 2018 Lenders are all accredited investors. The August 2018 Promissory Notes are unsecured, have a maturity dateremaining discount of August 30, 2021 and all principal is due upon maturity. Amounts borrowed accrue interest at 12% per annum and accrued interest is payable monthly. The Company also issued to the Lenders six-year warrants to purchase an aggregate of 1,500,000 shares of the Company’s common stock exercisable for cash at an exercise price of $0.35 per share. The fair value of the warrants amounted to $276,798 and was capitalized as deferred financing costs, of which $7,689 and $7,689 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.$17,302.

 

The Company recognized amortization and interest expenses in connectionwarrants issued with the credit facility and loans as follows.promissory note were valued using the Black-Scholes pricing method using the following assumptions below. 

 

  

Three months ended

  

Nine months ended

 
  

September 30,

  

September 30,

 
  

2018

  

2017

  

2018

  

2017

 
                 

Amortization expense associated with credit facility and loan

 $251,718  $64,560  $636,125  $180,204 

Interest expense associated with credit facility and loan

 $422,051  $217,695  $1,133,678  $613,240 

Other finance fees associated with credit facility and loan

 $4,646  $24,125  $45,886  $72,375 

Expected life in years

5

Stock price volatility

114.20%

Risk free interest rate

1.58%

Expected dividends

None 

Estimated forfeiture rate

None 

 


 

 

NOTE 6: STOCKHOLDERS’ DEFICIT

 

Common Stock

  

There were no exercisesOn June 20, 2019, the Company issued an aggregate of options3,500,000 restricted shares of common stock to certain promissory note holders as consideration for early payment of the promissory notes. The value of the shares issued amounted to $315,000 and was recorded as interest expense during the three and nine-month periodsnine months ended September 30, 2018.2019.

 

During the nine-month period ended September 30, 2017,On June 20, 2019, the Company issued 1,707,69230,000,000 restricted shares of its Common Stock pursuantcommon stock to Emerging Growth, LLC as part of the cashless exerciseacquisition under the Emerging Growth Agreement (see Note 4). The value of 2,400,000 options. 

Asthe stock amounted to $2,700,000 and was recorded as part of September 30, 2018, and December 31, 2017, there were 66,179,709 and 65,939,709 sharesthe acquisition price of Common Stock issued and outstanding, respectively.the net assets acquired under the Emerging Growth Agreement.

 

Restricted Stock Issued as Compensation

 

During 2017,2018, the Company issued 120,000an aggregate total of 240,000 restricted shares of its Common Stock, at a value of $0.50 per share, vesting in 4 equal quarterly increments commencing on July 1, 2017,common stock to each of its non-employee directors as partial annualdirector compensation, for services as a director. As of September 30, 2018, these restricted shares were fully issued. The Company recorded expenses of $30,000 and $60,000 during the three and nine-month periods ended September 30, 2018, respectively. $0 remained unvested as of September 30, 2018.

During the nine-month period ended September 30, 2018, the Company issued 120,000 restricted shares of its Common Stock, at a value of $0.50 per share, vesting in 4 equal quarterly increments commencing on July 1, 2018 to each of its non-employee directors as partial annual compensation for services as a director. As of Septemberand ending June 30, 2018, these restricted shares were fully issued.2019. The Company recorded expenses of $0 and $30,000 during the three and nine-month periodsmonths ended September 30, 2018. 90,000 shares remained unvested2019 and 2018, respectively, and $60,000 and $90,000 during the nine months ended September 30, 2019 and 2018, respectively. There was no remaining unrecorded compensation expense related to restricted stock as of September 30, 2018.2019.


Preferred Stock

The Company is authorized to issue 2,000,000 shares of preferred stock with a par value of $0.001 per share, of which 500 have been authorized as Series A Preferred Stock and 3,000 have been authorized as Series B Preferred Stock.

On June 20, 2019, the Company issued to certain of its promissory noteholders an aggregate of 500 shares of Series A Preferred Stock, each with a stated value per share of $1,000, as conversion of $500,000 worth of outstanding promissory notes. The Series A Preferred Stock bears interest at 12% per annum, and is convertible into the Company’s common stock at the election of the holder at a conversion price per share to be mutually agreed between the Company and the holder in the future, and be redeemable at the Company’s option following the third year after issuance, without voting rights or a liquidation preference.

On June 20, 2019, the Company issued 3,000 shares of Series B Preferred Stock to Emerging Growth, LLC, each with a stated value of $1,000 per share, as part of the Emerging Growth Agreement. The aggregate fair value of $687,000 was recorded as part of the acquisition price of the net assets acquired from Emerging Growth, LLC (see Note 4). The Series B Preferred Stock bears interest at 6% per annum and is convertible into the Company’s common stock at the election of Emerging Growth, LLC at a conversion price per share to be mutually agreed between the Company and Emerging Growth, LLC in the future, without voting rights or a liquidation preference, except with respect to accrued penalty interest.

For the three and nine months ended September 30, 2019, the Company incurred $60,000 and $66,575, respectively, of interest from the outstanding preferred stock.

 

Warrants

 

There were no exercises of warrants duringThe following summarizes the three and nine-month periodsCompany’s warrant activity for the nine months ended September 30, 2018. 2019.

          

Weighted-

 
          

Average

 
      

Weighted-

  

Remaining

 
      

Average

  

Contractual

 
      

Exercise

  

Life

 
  

Warrants

  

Price

  

(Years)

 
             

Outstanding at December 31, 2018

  25,045,517  $0.53   4.16 

Granted

  1,000,000   0.13     

Forfeited/cancelled

  (17,918,333)  0.50     

Outstanding at September 30, 2019 (unaudited)

  8,127,184  $0.56   3.38 
             

Vested and expected to vest at September 30, 2019 (unaudited)

  8,127,184  $0.56   3.38 
             

Exercisable at September 30, 2019 (unaudited)

  8,127,184  $0.56   3.38 

During the three and nine-month periodsmonths ended September 30, 2017,March 31, 2019, the Company issued 0500,000 warrants exercisable at a price of $0.15 per share which expire on January 25, 2024. The fair value of these warrants amounted to $44,670, and 160,096 shareswas recognized as deferred financing costs using the effective interest method during the three-month period ended March 31, 2019. Additionally, per the down round feature of its Common Stock7,935,000 warrants issued in connection with the Beedie Credit Agreement (see Note 7), pursuant to ASU 2017-11 which allows instruments with a down round feature to qualify for equity classification, the cashless exerciseCompany recognized the value of 225,000 warrants.the feature when it was activated and there was an actual reduction of the strike price or conversion feature. The reduction in income of such 7,935,000 warrants amounted to $104,638 and was capitalized as deferred financing costs during the three-month period ended March 31, 2019. In connection with the closing of the Asset Purchase Agreement for the sale of the CAKE Business on June 18, 2019, the above warrants were cancelled.

On September 10, 2019, the Company issued 500,000 warrants in connection with a promissory note payable (see Note 5).


 

During the three and nine-month periods ended September 30, 2018, the Company issued 3,835,000 and 12,135,000 warrants related to its loans, at a fair value of $689,281 and $2,727,577, respectively, and were recognized as deferred financing costs and amortized using the effective interest method over the term of the associated loan. During

The Company recorded expenses of $0 and $101,836 during the three and nine-month periodsmonths ended September 30, 2019 and 2018, respectively, related to warrants granted for compensation. The Company recorded expenses of $126,810 and $229,400 during the Company issued 1,000,000 and 1,500,000 warrants to employees at a fair value of $204,730 and $335,891 and 58,824 warrants expired, respectively.

During the three and nine-month periodsnine months ended September 30, 2017, 46,8752019 and 2018, respectively, related to warrants expired and the Company issued 1,000,000 warrants to the 2017 Lenders, exercisable at a price of $0.35 per share and which expire on August 14, 2020. The fair value of these warrants, which amounted to $104,676, were recognized as deferred financing fees and amortized using the effective interest method over the terms of the associated loan. 

granted for compensation. As of September 30, 2018,2019, all outstanding warrants were fully vested and December 31, 2017, there were 25,045,517 and 11,469,341 warrants issued and outstanding, respectively, with a weighted average price $0.53 and $0.74, respectively.was no remaining unrecorded compensation expense.

 

During the three and nine-month periods ended September 30, 2018 and 2017, the Company recorded expenses of $101,836 and $229,400 and $125,867 and $377,600, respectively.

 

Options

 

The Company generally recognizes its share-based payment overfollowing summarizes the vesting terms ofCompany’s stock option activity for the underlying options.nine months ended September 30, 2019.

 

  

Nine-month periods ended

September 30,

 
  

2018

  

2017

 

Weighted-average grant date fair value

 $-  $- 

Fair value of options, recognized as selling, general, and administrative expenses

 $23,298  $166,397 

Number of options granted

  -   - 
          

Weighted-

 
          

Average

 
      

Weighted-

  

Remaining

 
      

Average

  

Contractual

 
      

Exercise

  

Life

 
  

Options

  

Price

  

(Years)

 
             

Outstanding at December 31, 2018

  7,232,500  $0.40   3.45 

Forfeited/cancelled

  (637,500)  1.00     

Outstanding at September 30, 2019 (unaudited)

  6,595,000  $3.40   2.60 
             

Vested and expected to vest at September 30, 2019 (unaudited)

  6,595,000  $0.34   2.60 
             

Exercisable at September 30, 2019 (unaudited)

  6,595,000  $0.34   2.60 

 

As of September 30, 2018 and December 31, 2017, there were 7,237,500 and 8,302,500 options, respectively, issued and outstanding with a weighted average price of $0.40 and $0.40 respectively.

 

The Company recorded expenses of $0 and $7,376 during the three months ended September 30, 2019 and 2018, respectively, related to stock options. The Company recorded expenses of $10,963 and $23,298 during the nine months ended September 30, 2019 and 2018, respectively, related to stock options. Employees with unvested stock options all left the Company in connection with the closing of the Asset Purchase Agreement for the sale of the CAKE Business on June 18, 2019. As a result, no further options are expected to vest, and the total compensation cost related to non-vested awards not yet recognized amounted to $18,457$0 at September 30, 2019.


NOTE 7: DISCONTINUED OPERATIONS

During May 2019, the Company decided to discontinue most of its operating activities pursuant to the Asset Purchase Agreement entered into with CAKE Software, Inc. (see Note 1).

In accordance with the provisions of ASC 205-20, the Company has separately reported the assets and liabilities of the discontinued operations in the unaudited condensed consolidated balance sheets. The assets and liabilities have been reflected as discontinued operations in the consolidated balance sheets as of September 30, 2019 and December 31, 2018, and consist of the Company expects that it will be recognized over the following 24 months.following:

  

September 30,

  

December 31,

 
  

2019

  

2018

 
  

(Unaudited)

     

Current assets of discontinued operations

        

Accounts receivable, net [1]

 $-  $2,081,551 

Prepaid expenses and other assets

  -   254,760 

Total current assets of discontinued operations

 $-  $2,336,311 
         

Noncurrent assets of discontinued operations

        

Property and equipment, net [2]

 $-  $52,035 

Other assets

  -   108,211 

Total noncurrent assets of discontinued operations

 $-  $160,246 
         

Current liabilities of discontinued operations

        

Accounts payable and accrued expenses

 $76,028  $3,018,394 

Deferred revenues [3]

  -   443,650 

Credit facility, short term [4]

  -   3,399,240 

Total current liabilites of discontinued operations

 $76,028  $6,861,284 
         

Noncurrent liabilities of discontinued operations

        

Credit facility, net of unamortized financing costs [4]

 $-  $5,888,155 

Other loan, related party net of unamortized financing costs [5]

  -   386,686 

Other long-term loan, net of unamortized financing costs [5]

  -   2,273,402 

Other liabilities

  -   637,500 

Total noncurrent liabilites of discontinued operations

 $-  $9,185,743 

[1]

The Company’s accounts receivable was due primarily from advertisers and marketers. Collateral was not required. The Company also maintained allowances for doubtful accounts for estimated losses resulting from the inability of the Company’s customers to make payments. The Company periodically reviewed these estimated allowances, including an analysis of the customers’ payment history and creditworthiness, the age of the trade receivable balances and current economic conditions that may affect a customer’s ability to make payments as well as historical collection trends for its customers as a whole. Based on this review, the Company specifically reserved for those accounts deemed uncollectible or likely to become uncollectible. When receivables were determined to be uncollectible, principal amounts of such receivables outstanding were deducted from the allowance. The allowance for doubtful accounts amounted to $0 and $245,736 at September 30, 2019 and December 31, 2018, respectively.

 


 

[2]

The Company’s property and equipment consisted of the following.

  

September 30,

  

December 31,

 
  

2019

  

2018

 
  

(Unaudited)

     
         

Computer equipment and software

 $-  $422,441 

Office furniture and equipment

  -   123,932 

Leasehold improvements

  -   288,937 
         
   -   835,310 
         

Less: accumulated depreciation

  -   (783,275)
         
  $-  $52,035 

NOTE 7: COMPREHENSIVE LOSS

 

Comprehensive loss includes changes in equity relatedDepreciation expense from discontinued operations amounted to foreign currency translation adjustments. The following table sets forth the reconciliation from net loss to comprehensive loss$0 and $10,035 for the three and nine-month periodsmonths ended September 30, 20172019 and 2016:

  

Three months ended

  

Nine months ended

 
  

September 30,

  

September 30,

 
  

2018

  

2017

  

2018

  

2017

 

Net loss

 $(1,963,137

)

 $(695,745

)

 $(4,783,640

)

 $(1,367,678

)

Other comprehensive loss:

                

Foreign currency translation adjustment

  (7,166

)

  12,841   (20,683

)

  32,098 

Comprehensive loss

 $(1,970,303

)

 $(682,904

)

 $(4,804,323

)

 $(1,335,580

)

The following table sets forth the balance in accumulated other comprehensive loss as of September 30, 2018, respectively. Depreciation expense amounted to $31,042 and December 31, 2017, respectively:

  

September 30,

2018

  

December 31,

2017

 

Accumulated other comprehensive loss

 $(62,223

)

 $(41,540

)

NOTE 8: SEGMENTS

The Company operates in one business segment. Percentages of sales by geographic region$35,747 for the three and nine-month periodsnine months ended September 30, 20172019 and 2016 were approximately2018, respectively. The deprecation expense for each period is reflected as follows:a component of discontinued operations.

 

  

Three months ended

  

Nine months ended

 
  

September 30,

  

September 30,

 
  

2018

  

2017

  

2018

  

2017

 

United States

  64%   56%   62%   58% 

Europe

  15%   18%   17%   20% 

Other

  21%   26%   21%   22% 

NOTE 9: COMMITMENTS AND CONTINGENCIES

During August 2017, the Company entered into an amendment to its original January 2014 lease for certain office space in Newport Beach.  Pursuant to the lease amendment, effective March 1, 2018, the premises shall be expanded to include an additional 1,332 usable square feet such that the premises shall consist of 11,728 usable square feet in the aggregate. In addition, pursuant to the terms of the lease amendment, the Company extended the term of the lease agreement until June 30, 2023. Commencing on March 1, 2018, the initial base rent for the premises is $38,702 per month for the first year and increasing to $44,566 per month by the end of the term.

During October 2016, the Company amended its original May 2014 sublease and entered into a 21-month sublease in Newport Beach, effective June 1, 2016. The monthly base rent was approximately $4,100 through the end of the sublease term, in February 2018. As of September 30, 2018, this sublease has expired.

During July 2014, the Company entered into a five-year lease for certain office space in a business center in London, England, which commenced on July 30, 2014. The base rent is GBP 89,667 (approximately $115,000) per year and the estimated service charges for the lease are GBP 45,658 (approximately $56,000) per year.

Legal Proceedings

From time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently a party to any legal proceedings that it currently believes, if determined adversely to the Company, would individually or taken together have a material adverse effect on the Company’s business, operating results, financial condition or cash flows.

On November 29, 2016, the Company entered into the Settlement Agreement with Jeff McCollum, or McCollum, to settle pending litigation between the Company and McCollum in the Superior Court of the State of California related to McCollum’s termination as an executive officer of the Company on September 8, 2014. In connection with the Settlement Agreement, McCollum surrendered to the Company a stock certificate representing 1,890,000 shares of the Company’s Common Stock, or the Shares, and for dismissal with prejudice of the cross-complaint and action against the Company brought by McCollum. The Company agreed to pay McCollum a total of $2,700,000. $1,000,000 of this total has already been paid as of January 18, 2017, of which the Company’s insurance carrier contributed $500,000. The remaining $1,700,000 will be paid in 48 equal monthly installments starting on July 1, 2017. The Company previously cancelled McCollum’s options to purchase up to 6,600,000 shares of the Company’s Common Stock at exercise prices of $0.15 or $0.31 per share. The Company cancelled the 1,890,000 Shares and thereafter the Company’s issued and outstanding common stock decreased by approximately 3%. During 2016, the Company recorded a loss on legal settlement of $2,200,000, net of the reimbursement of $500,000, which the Company received from its insurance carrier in December 2016. The outstanding settlement balance amounted to $1,168,750 and $1,487,500 as of September 30, 2018 and December 31, 2017, respectively, pursuant to the Settlement Agreement, of which $425,000 has been classified as accounts payable and accrued expenses as of September 30, 2018 and December 31, 2017 and $743,750 and $1,062,500, respectively, as other long-term liabilities, in the accompanying condensed consolidated balance sheet.

NOTE 10: SUBSEQUENT EVENTS

None


ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with the financial statements and related notes included elsewhere in this report and our Annual Report on Form 10-K for the year ended December 31, 2017. Certain statements in this discussion and elsewhere in this report constitute forward-looking statements. See “Cautionary Statement Regarding Forward Looking Information’’ elsewhere in this report. Because this discussion involves risk and uncertainties, our actual results may differ materially from those anticipated in these forward-looking statements

Overview

We own and operate CAKE and getcake.com, a marketing technology company that provides a proprietary solution for advanced analytics, attribution and campaign optimization for digital marketers. Our powerful software-as-a service, or SaaS, is an enterprise solution that has been an industry standard for advertisers, agencies, networks and publishers to measurably analyze and improve digital advertising spend. We currently have over 500 customers driving billions of consumer actions monthly through the CAKE enterprise platform.

In late 2017, we introduced Journey by CAKE, a new product family created specifically for brand advertisers and digital agencies. Journey by CAKE is a cloud-based solution that collects and analyzes customer journey data using multi-touch attribution for marketing campaign optimization. Journey by CAKE delivers accurate and actionable insights about the previously missing steps of the anonymous customer journey. With this extended view into vital customer interactions, Journey provides the intelligence needed to move unknown consumers to known customers, boosting campaign performance and return on advertising spend (RoAS). The main features are: Insights, a centralized dashboard which provides valuable customer journey insights that drive real-time decisions; Attribution, campaign spend optimization based on positional and data-driven attribution of key steps in the customer journey; and Connections, seamless integrations with digital media and marketing tools which make collecting customer journey data easier than ever. Journey by CAKE enables brands to move beyond the confines of siloed data and provides customer journey analytics for marketers, in real time.

On January 12, 2017, we announced that the CAKE platform was significantly enhanced with a new unified technical architecture and platform to collect and support high-traffic volumes. Now our industry-leading technology not only gathers granular information about the customer path to conversion, but also leverages data science and machine learning to further understand and maximize RoAS. Additionally, our patent-pending algorithmic attribution for predictive analytics clearly and accurately show marketers how to optimize campaigns. These new capabilities enhance our existing rules-driven attribution to programmatically allow marketers to analyze complex customer journeys; arming advertisers with more actionable insights needed to effectively measure the true impact of each media channel and maximize revenue for any given level of spending. 

The CAKE SaaS proprietary marketing platform is used by some of the world’s leading companies and largest customer-base of enterprise performance marketing networks and advertisers. CAKE’s platform is based on reliable, feature rich technology and is bolstered by the industry’s leading customer service and top-tier technology partners, assuring the highest level of uptime.

On February 14, 2017, Gartner, Inc. once again named us as a Vendor to Watch in its “Magic Quadrant for Digital Marketing Hubs” report. This research is intended for chief marketing officers (CMOs), chief marketing technologists and other digital marketing leaders involved in the selection of core systems to support digital marketing business requirements. According to Gartner, our solution enables hub-like multichannel data management and onboarding capabilities. CAKE is for enterprise performance marketers looking to track attribution and optimize data-driven lead generation and customer acquisition through affiliate and other digital marketing channels.  

Our revenue model is based on monthly recurring license fees, usually pursuant to an annual contract. The contracts typically include a prescribed volume of clicks, impressions, or other events, and are subject to overage charges for volumes in excess of the included amounts. We also charge training and implementation fees, and in certain cases, professional services fees and royalties. A majority of our revenue is derived from customers in the United States. During November 2012, we formed Cake Marketing UK Ltd, a private limited company, which is our wholly-owned subsidiary located in the United Kingdom in order to better provide our services in the European market.

Our business is currently headquartered in Newport Beach, California, with operations in Santa Monica, California, London, England and New Delhi, India, allowing us to provide global support to our customer base. The CAKE platform supports multiple languages and currencies so online marketers can track the performance of their marketing campaigns and better target their digital spend on a global scale.

Our training, support personnel, hosting and cloud-based infrastructure contribute to our cost of operating the business. We anticipate spending in these areas will remain approximately constant during the remainder of 2018. In addition, development resources were required to continue to enhance our products. Those resources were used to extend our software platform and to create deeper integrations to third-party technologies that include, but are not limited to, Google AdWords, Bing Ads, Facebook, DoubleClick Campaign Manager (DCM), Marketo and others. 

We intend to continue to invest in sales, marketing, product development and innovation. We allocated a portion of our marketing budget to being present at tradeshows, securing coverage in industry publications, and providing the support documentation required by sales initiatives. Additional efforts will be made to speak at industry events, write for media outlets and implement digital marketing campaigns, increasing awareness of the CAKE solutions and the thought leadership driving product development.

Our principal offices are located at 20411 SW Birch Street, Suite 250, Newport Beach, CA 92660. Our telephone number there is: (949) 548-2253. Our corporate website is: www.accelerize.com, the contents of which are not part of this quarterly report.

Our Common Stock is quoted on the OTCQB Marketplace under the symbol "ACLZ."  


Results of Operations

ACCELERIZE INC.

UNAUDITED CONDENSED CONSOLIDATED RESULTS OF OPERATIONS

  

Three-month periods

          

Nine-month periods

         
  

ended September 30,

  $    

%

  

ended September 30,

  $    

%

 
  

2018

  

2017

  

Change

  

Change

  

2018

  

2017

  

Change

  

Change

 
                                 

Revenues:

 $5,292,304  $6,065,674   (773,370)  -12.7% $16,682,730  $18,016,552   (1,333,822)  -7.4%

Cost of revenue

  2,042,435   2,749,975   (707,540)  -25.7%  6,865,431   6,660,684   204,747   3.1%

Gross Profit

  3,249,869   3,315,699   (65,830)  -2.0%  9,817,299   11,355,868   (1,538,569)  -13.5%
                                 

Operating expenses:

                                

Research and development

  1,033,707   1,031,878   1,829   0.2%  3,144,106   3,208,434   (64,328)  -2.0%

Sales and marketing

  1,127,055   1,119,302   7,753   0.7%  3,359,247   3,419,095   (59,848)  -1.8%

General and administrative

  2,372,359   1,554,982   817,377   52.6%  6,278,522   5,232,896   1,045,626   20.0%

Total operating expenses

  4,533,121   3,706,162   826,959   22.3%  12,781,875   11,860,425   921,450   7.8%
                                 

Operating loss

  (1,283,252)  (390,463)  (892,789)  228.6%  (2,964,576)  (504,557)  (2,460,019)  487.6%
                                 

Other income (expense):

                                

Other income

  (222)  2   (224)  -11200.0%  564   744   (180)  -24.2%

Other expense

  (679,663)  (305,284)  (374,379)  -122.6%  (1,819,628)  (863,865)  (955,763)  -110.6%

Total other expenses

  (679,885)  (305,282)  (374,603)  -122.7%  (1,819,064)  (863,121)  (955,943)  -110.8%
                                 

Net loss

 $(1,963,137) $(695,745)  (1,267,392)  -182.2% $(4,783,640) $(1,367,678)  (3,415,962)  -249.8%

[3]

The Company’s deferred revenue represented prepayments made by certain customers and undelivered implementation and training fees.  The Company decreased the deferred revenues by the amount of the services it rendered to such clients when provided.

 

 

Discussion of Results for Three-Month and Nine-Month Periods Ended September 30, 2018 and 2017

Revenues

  

Three Months Ended

September 30,

  

 

%

  

Nine Months Ended

September 30,

  

 

%

 
  

2018

  

2017

  

Change

  

2018

  

2017

  

Change

 

Revenues

 $5,292,304  $6,065,674   -12.7%  $16,682,730  $18,016,552   -7.4% 

We generate revenues from monthly recurring license fees, overage fees (based on volume of transactions processed), training and implementation fees, and in certain cases, professional services fees and royalties. Our revenue breakdown for the three and nine-month periods ended September 30, 2018 and 2017 were as follows.

  

Three Months Ended

      

Nine Months Ended

     
  

September 30,

  

%

  

September 30,

  

%

 
  

2018

  

2017

  

Change

  

2018

  

2017

  

Change

 
                         

License

 $4,293,722  $4,828,655   -11.1%  $13,427,454  $14,654,627   -8.4% 

Overage

  774,117   1,000,218   -22.6%   2,528,472   2,656,909   -4.8% 

Other

  224,464   236,801   -5.2%   726,804   705,016   3.1% 

Total

 $5,292,304  $6,065,674   -12.7%  $16,682,730  $18,016,552   -7.4% 

The decrease in total revenues during the three and nine-month periods ended September 30, 2018, when compared to the same periods in 2017, is mainly due to a decrease in overage fees as a result of our decision to terminate our relationship with a major customer.

The decrease in our software licensing revenues during the three and nine-month periods ended September 30, 2018, when compared to the same periods in 2017, is largely due to our decision to terminate a major customer, combined with reductions in transaction volume for several other customers. Our monthly recurring license fee revenue, which constitutes the contractually recurring portion of our revenue and comprises the bulk of our total revenue, or 80% for the nine-month period ended September 30, 2018, decreased approximately 11% and 8% year over year during the three and nine-month periods ended September 30, 2018, respectively, when compared to the same periods in 2017. In addition to impacting licensing revenues, reduced transaction volume also impacted overage fees, which decreased approximately 23% and 5% year over year during the three and nine-month periods ended September 30, 2018, respectively, when compared to the same periods in 2017. Our average monthly revenue per customer decreased approximately 10% and 4% during the three and nine-month periods ended September 30, 2018, respectively, when compared to the same periods in 2017.

[4]

A summary of the amounts previously outstanding under the Company’s credit facilities are as follows:

 


We believe that there was substantial uncertainty and caution among some of our customers and our affiliate networks’ customers in reaction to the European Union’s recently instituted General Data Protection Regulation (GDPR). We believe this led to delays in some purchase decisions by new customers, as well as a temporary reduction in advertising activity among some current customers – likely contributing to our lower transaction volume and associated lower revenue.

Cost of Revenues

  

Three Months Ended

September 30,

  

%

Change

  

Nine Months Ended

September 30,

  

%

Change

 
  

2018

  

2017

      

2018

  

2017

     
                         

Cost of revenues

 $2,042,435  $2,749,975   -25.7%  $6,865,431  $6,660,684   3.1% 

Cost of revenues consists primarily of web hosting and personnel costs associated with supporting customer on-boarding and training activities, including salaries, benefits, and related infrastructure costs. Web hosting fees are partially correlated to our revenues, depending on each specific agreement we have with our customers. The majority of our customers’ services are hosted on non-dedicated servers, on which capacity can be maximized by server, while certain customers prefer to have their services hosted on dedicated servers, on which capacity can only be maximized by customer and by server. Additionally, our resources associated with on-boarding are usually allocated at the beginning of the relationship with the new customer (usually, the first two months). Accordingly, our personnel costs associated with supporting customer on-boarding activities are not necessarily correlated with our revenues.

During the three and nine-month periods ended September 30, 2018, when compared to the same periods in 2017, cost of revenues decreased reflecting the lower web hosting fees of approximately $313,000 and increased reflecting the higher web hosting fees of approximately $647,000, respectively, incurred to support our customers and platform usage.

We believe that our cost of revenues will remain approximately constant during the remainder of 2018.

Research and Development Expenses

  

Three Months Ended

September 30,

  

%

Change

  

Nine Months Ended

September 30,

  

%

Change

 
  

2018

  

2017

      

2018

  

2017

     
                         

Research and development

 $1,033,707  $1,031,878   0.2%  $3,144,106  $3,208,434   -2.0% 

Research and development expenses consist primarily of personnel costs associated with the enhancement and maintenance of our SaaS product offerings, consisting of salaries, benefits, and related infrastructure costs, offset by capitalized software development costs.  

Our research and development expenses remained constant and slightly decreased during the three and nine-month periods ended September 30, 2018, respectively, when compared to the same periods in 2017. The decrease was mainly due to lower capitalization of software development costs.

We believe that our research and development expenses will slightly increase during the remainder of 2018 as we continue to enhance features of our SaaS platform.

Sales and Marketing Expenses

  

Three Months Ended

September 30,

  

%

Change

  

Nine Months Ended

September 30,

  

%

Change

 
  

2018

  

2017

      

2018

  

2017

     

Sales and marketing

 $1,127,055  $1,119,302   0.7%  $3,359,247  $3,419,095   -1.8% 


Sales and marketing expenses consist primarily of personnel costs associated with the sale and marketing of our SaaS products, including salaries, benefits, and related infrastructure, as well as the costs of related marketing programs, such as trade shows and public relations.

We experienced a slight decrease in sales and marketing expenses during the nine-month period ended September 30, 2018, when compared to the same period in 2017, mainly due to a decrease in sales commissions.

We believe that our sales and marketing expenses will increase slightly in 2018 as we continue to execute on proven marketing programs.

General and Administrative Expenses

  

Three Months Ended

September 30,

  

%

Change

  

Nine Months Ended

September 30,

  

%

Change

 
  

2018

  

2017

      

2018

  

2017

     
                         

General and administrative

 $2,372,359  $1,554,982   52.6%  $6,278,522  $5,232,896   20.0% 

General and administrative expenses primarily consist of personnel costs associated with the support of our operations consisting of salaries, benefits, and related infrastructure. Also included are non-personnel costs, such as audit and legal fees, as well as professional fees, insurance, investor relations, and other corporate expenses.

The increase in general and administrative expenses during the three and nine-month periods ended September 30, 2018, when compared to the same periods in 2017, is primarily due to higher legal expenses of approximately $267,000, mostly related to work on our credit facility and loans, higher bad debt expenses of approximately $385,000, higher rent expenses of approximately $100,000, and approximately $120,000 in higher compensation related expenses.

We believe that our general and administrative expenses will remain approximately constant during the remainder of 2018.

Other Income

  

Three Months Ended

September 30,

  

%

Change

  

Nine Months Ended

September 30,

  

%

Change

 
  

2018

  

2017

      

2018

  

2017

     
                         

Other (loss) income

 $(222

)

 $2   -11200.0%  $564  $744   -24.2% 

Other Income during the three and nine-month periods ended September 30, 2018 consisted of small gain or loss on foreign exchange.

Other Expenses

  

Three Months Ended

September 30,

  

%

Change

  

Nine Months Ended

September 30,

  

%

Change

 
  

2018

  

2017

      

2018

  

2017

     
                         

Other expenses

 $679,663  $305,284   -122.6%  $1,819,628  $863,865   -110.6% 

Other expenses consist of interest charges and amortization of deferred financing costs associated with our credit facility and loans.

The increase in interest expenses during the three and nine-month periods ended September 30, 2018, when compared to the same periods in 2017, is primarily due to higher levels of borrowings we have made from time to time.

Liquidity and Capital Resources

We had a working capital deficit of $2,024,625 and an accumulated deficit of $36,326,324 as of September 30, 2018.  We also had a net loss of $4,783,640 and cash used in operating activities of $2,769,540 as of September 30, 2018.


Our plan to continue as a going concern includes raising capital in the form of debt or equity, increased gross profit from revenue growth and managing and reducing operating and overhead costs. During the second quarter of 2018, we engaged a nationally recognized investment bank to assist us in pursuing strategic transactions including acquisitions, dispositions, capital raising and debt restructuring. However, we cannot provide any assurances that we will be successful in accomplishing our plans. We also cannot provide any assurance that unforeseen circumstances that could occur at any time within the next twelve months or thereafter will not increase the need for us to raise additional capital on an immediate basis. These matters, among others, raise substantial doubt about our ability to continue as a going concern. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should we be unable to continue as a going concern.

  

Ending balance at

September 30,

  

Average balance during

nine-months ended

September 30,

 
  

2018

  

2017

  

2018

  

2017

 

Cash

 $1,808,029  $634,772  $987,456  $1,157,450 

Restricted cash

  50,000   50,000   50,000   50,000 

Accounts receivable

  2,130,476   2,474,511   2,411,556   2,352,061 

Accounts payable and accrued expenses

  2,278,096   2,344,121   2,378,590   2,491,565 

Short term credit facility, net of deferred financing cost

  3,501,487   2,736,684   3,278,650   2,387,815 

Short term loan, net of deferred financing cost

  -   839,403   612,097   673,135 

Credit facility, net of deferred financing cost

  6,404,754   4,498,346   5,403,871   4,543,287 

Other loan, related party net of deferred financing cost

  369,791   -   184,896   - 

Other loan net of deferred financing cost

  2,205,795   379,853   1,236,867   189,927 

Long term other liabilities

  743,750   1,168,750   903,125   1,328,125 

At September 30, 2018 and 2017, 44% and 42%, respectively, of our total assets consisted of cash and cash equivalents and accounts receivable.

We extend unsecured credit in the normal course of business to our customers. The determination of the appropriate amount of the reserve for uncollectible accounts is based upon a review of the amount of credit extended, the length of time each receivable has been outstanding, and the specific customers from whom the receivables are due.

The objective of liquidity management is to ensure that we have ready access to sufficient funds to meet commitments while implementing our growth strategy. Our primary sources of liquidity historically include the sale of our securities and borrowings from our credit facilities and loans.

We do not have any material commitments for capital expenditures of tangible items.

Agility Loan

On March 11, 2016, we entered into a subordinated loan with Agility Capital which provides for total availability of $625,000 and was to originally mature, prior to amendment, on March 31, 2017. The Agility Loan has a fixed interest rate of 12% per year and requires $25,000 monthly amortization payments beginning on June 1, 2016. The Agility Loan also requires fees of approximately $130,000 over the life of the loan and is subject to a total aggregate minimum interest of $50,000 in the event of a prepayment. The Agility Loan contains covenants to achieve specified Adjusted EBITDA levels, as defined, limiting capital expenditures, restricting our ability to pay dividends, purchase and sell assets outside the ordinary course and incur additional indebtedness. As of December 31, 2017, and at repayment of the Agility Loan, we were in compliance with these covenants. The Agility Loan requires a security interest in all of our personal property and intellectual property, second in priority to SaaS Capital Funding II, LLC.

In connection with the Agility Loan, on June 30, 2016, as a result of outstanding amounts under the Agility Loan, we issued to Agility Capital a warrant to purchase up to 69,444 shares of our Common Stock at an exercise price of $0.45 per share. This warrant expires on March 11, 2021. The fair value of the warrant amounted to $15,880 and was capitalized as deferred financing costs, of which $0 and $3,970 was expensed during the three and nine-month periods ended September 30, 2017, respectively, and $0 was expensed during 2018.

On November 29, 2016, we entered into an amendment of our Agility Loan which waived any event of default and the breach of any covenant, representation, warranty, and any other agreement contained in the Agility Loan as a result of our entering into the Settlement Agreement. On the date of the amendment, a loan modification fee in the amount of $100,000, fully earned and non-refundable, was added to the outstanding loan balance. Additionally, the maturity date was extended to December 31, 2017. On November 29, 2016, we issued to Agility Capital a warrant to purchase up to 187,500 shares of our Common Stock at an exercise price of $0.40 per share. This warrant expires on November 29, 2021. The fair value of the warrant amounted to $42,427 and was capitalized as deferred financing costs, of which $9,791 and $29,372 was expensed during the three and nine-month periods ended September 30, 2017, respectively, and $0 was expensed during 2018.


On August 14, 2017, we entered into a consent to waiver of the Agility Loan, to permit the issuance of the 2017 Promissory Notes.

On November 8, 2017, we entered into the Third Amendment whereby Agility Capital agreed to loan an additional $300,000 to us, such that the aggregate principal amount owing to Agility Capital as of November 9, 2017 was $625,000. The Third Amendment extended the maturity date of the Agility Loan from December 31, 2017 to December 31, 2018. A loan modification fee of $125,000 was deducted from the Additional Loan amount. This arrangement was treated as a substantial modification of existing debt pursuant to the guidance of ASC 470-50 “Debt – Modifications and Extinguishments” (“ASC 470-50”). Because the net present value of the modified notes was greater than 10% of the present value of the remaining cash flows under the old debt, the transaction was treated as a debt extinguishment and reissuance of a new debt instrument, with the fair value of $606,034 and therefore recorded $106,034 as a loss on debt extinguishment.  The carrying value of the $625,000 did not change as a result of the extinguishment since the discounts recognized at inception of these new notes were fully amortized at the time of the issuance. 

On January 26, 2018, we repaid the Agility Loan by paying Agility Capital approximately $581,000 which terminated the loan agreement between us and Agility Capital and released Agility Capital’s security interest in our assets. We owed $0 and $600,000 under the Agility Loan at September 30, 2018 and December 31, 2017, respectively.

Credit Facility - SaaS Capital Loan

On May 5, 2016, we entered into the SaaS Capital Loan, with SaaS Capital Funding II, LLC to borrow up to a maximum of $8,000,000. Initial amounts borrowed will accrue interest at the rate of 10.25% per annum with future amounts borrowed bearing interest at the greater of 10.25% or 9.21% plus the three-year treasury rate at the time of advance. Accrued interest on amounts borrowed is payable monthly for the first six months and thereafter 36 equal monthly payments of principal and interest is payable. Prepayments will be subject to a 10%, 6% or 3% of principal premium if prepaid prior to 12 months, between 12 and 24 months, or between 24 months and maturity, respectively. Advances may be requested until May 5, 2018. The initial minimum advance amount of $5,000,000, on May 5, 2016, was used to repay the outstanding line of credit balance of $4,572,223. A facility fee of $80,000 was paid by us in connection with the initial advance and an additional $80,000 was paid in May 2017. Additionally, we incurred initial financing costs of $160,000 which was capitalized as deferred financing costs, of which $13,333 and $40,000 was expensed during the three and nine-month periods ended September 30, 2018 and 2017, respectively.

The SaaS Capital Loan contains customary covenants including, but not limited to, covenants to achieve specified Adjusted EBITDA levels and revenue renewal levels, limiting capital expenditures and restricting our ability to pay dividends, purchase and sell assets outside the ordinary course and incur additional indebtedness. As of September 30, 2018, we were in compliance with such covenants. The occurrence of a material adverse change will be an event of default under the SaaS Capital Loan, in addition to other customary events of default. We granted SaaS Capital Funding II, LLC a security interest in all of our personal property and intellectual property through the SaaS Capital Loan and the Patent, Trademark and Copyright Security Agreement between us and SaaS Capital Funding II, LLC.

On May 5, 2016, in connection with the SaaS Capital Loan, we issued to SaaS Capital Partners II, LP, an affiliate of SaaS Capital Funding II, LLC, a warrant to purchase up to 1,333,333 shares of our common stock at an exercise price of $0.45 per share subject to certain adjustments for dividends, splits or reclassifications. The Warrant is exercisable until the earlier of May 5, 2026, or the date that is 5 years from the date our equity securities are first listed for trading on NASDAQ. We paid approximately $169,000 in financing costs through December 31, 2016. The fair value of the warrant amounted to $383,128 and was capitalized as deferred financing costs, of which $31,927 and $95,781 was expensed during the three and nine-month periods ended September 30, 2018 and 2017, respectively.

On November 29, 2016, we entered into an amendment of our SaaS Capital Loan to receive consent from SaaS Capital to enter into the Settlement Agreement. The amendment required a loan modification fee of $120,000, payable at $10,000 a month for one year, expensed in the statement of operations. In connection with this amendment, we agreed to issue SaaS Capital a warrant to purchase up to 200,000 shares of our Common Stock at an exercise price of $0.36 per share. This warrant expires on November 29, 2026. The fair value of the warrant amounted to $60,185 and was fully expensed at December 31, 2016.

On May 10, 2017, we entered into a second amendment of the SaaS Capital Loan which adjusts the Minimum Adjusted EBITDA covenant in Schedule 6.17 of the SaaS Capital Loan from $0 to ($150,000) until August 31, 2017 to give us added flexibility in completing our hosting migration to a new platform and to allow for potentially augmented marketing and sales efforts.

On June 16, 2017, we entered into a third amendment of the SaaS Capital Loan to provide that any advance made within 6 months of the final advance date will be for a 36 month period with interest only payments due from the date of advance until the final advance date.

On August 14, 2017, we entered into a fourth amendment of the SaaS Capital Loan to permit the issuance of the 2017 Promissory Notes.


On November 8, 2017, we entered into the Fifth Amendment which adjusted the Minimum Adjusted EBITDA covenant of the SaaS Capital Loan from $0 to ($170,000) until October 31, 2017, to ($150,000) from November 1, 2017 to December 31, 2017, to ($100,000) from January 1, 2018 to May 31, 2018, to ($50,000) from June 1, 2018 to August 31, 2018, and to $0 thereafter. The Fifth Amendment added a new minimum liquidity covenant for a cash balance of $600,000 effective January 31, 2018. The Fifth Amendment also memorialized SaaS Capital’s waiver of the Minimum Adjusted EBITDA covenant for September 2017. In connection with the Fifth Amendment, the Company agreed to pay to SaaS Capital a fee of $375,000 upon the payment in full of all outstanding advances. 

On January 25, 2018, we entered into the Sixth Amendment to permit the Company to enter into the Beedie Credit Agreement, further described below, and to permit the repayment of Agility Capital and of the 2017 Promissory Notes. The Sixth Amendment also amended our adjusted EBITDA covenant and added covenants requiring a minimum gross margin and specified debt to monthly recurring revenue ratios. This arrangement was treated as a normal modification of existing debt pursuant to the guidance of ASC 470-50 “Debt – Modifications and Extinguishments” (“ASC 470-50”). Because the net present value of the modified notes was lesser than 10% of the present value of the remaining cash flows under the old debt, the transaction was treated as a debt modification. In connection with the Sixth Amendment, we agreed to issue SaaS Capital a warrant to purchase up to 200,000 shares of our Common Stock at an exercise price of $0.35 per share, subject to certain adjustments for dividends, splits or reclassifications. The fair value of the warrant amounted to $56,834 and was capitalized as deferred financing costs, of which $4,736 and $12,629 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.

On May 31, 2018, we entered into the Seventh Amendment to permit the issuance of the 2018 Promissory Notes to amend our adjusted EBITDA, revenue renewal and total debt to monthly recurring revenue covenants, to increase the success fee payable upon repayment of the facility by $120,000 to $495,000, and to fix prepayment penalties until October 31, 2018.

On June 13, 2018, we entered into the Eighth Amendment to issue additional 2018 Promissory Notes.

On August 31, 2018, we entered into the Ninth Amendment to permit the issuance of the August 2018 Promissory Notes to amend our minimum adjusted EBITDA, revenue renewal, total debt to monthly recurring revenue and secured debt to monthly recurring revenue covenants, to increase the success fee payable upon repayment of the facility to $555,000 and to provide for twice monthly reporting of our projected cash flows..

During the nine-month period ended September 30, 2018, we borrowed $350,000 from the SaaS Capital Loan, and made principal payments of $2,402,653.

We owed $5,651,731 and $7,704,384 under the SaaS Capital Loan at September 30, 2018 and December 31, 2017, respectively.

2017 Promissory Notes

On August 14, 2017, we borrowed an aggregate of $1,000,000 from seven lenders and issued promissory notes for the repayment of the amounts borrowed. The 2017 Lenders are all accredited investors, certain of the 2017 Lenders are shareholders of ours, one of the 2017 Lenders is an affiliate of our director, Greg Akselrud, and two of the 2017 Lenders are each affiliated with a partner of Mr. Akselrud’s in the law firm of Stubbs Alderton and Markiles, LLP. The 2017 Promissory Notes are unsecured, have a maturity date of August 14, 2019 and all principal is due upon maturity. Amounts borrowed accrue interest at 12% per annum and accrued interest is payable monthly. We also issued to the 2017 Lenders three-year warrants to purchase an aggregate of 1,000,000 shares of our Common Stock at an exercise price of $0.35 per share. The fair value of the warrant amounted to $104,676 and was capitalized as deferred financing costs, of which $0 and $82,868 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $8,723 and $8,723 was expensed during the three and nine-month periods ended September 30, 2017.

On January 26, 2018, we paid approximately $1,074,000 to repay the 2017 Promissory Notes which includes approximately $65,000 in additional interest expenses due to the repayment date which was prior to the maturity date. We owed $0 and $1,000,000 under the 2017 Promissory Notes at September 30, 2018 and December 31, 2017 respectively.

  

September 30,

  

December 31,

 
  

2019

  

2018

 
  

(Unaudited)

     
         

Saas Capital Loan

 $-  $4,810,135 

Less: deferred financing costs

  -   (100,867)

Saas Capital Loan, net

  -   4,709,268 
         

Beedie Credit Agreement

$-$6,000,000

On January 25, 2018, we entered into a non-revolving term credit agreement with Beedie to borrow up to a maximum of $7,000,000. Outstanding principal will accrue interest at the rate of 12% per annum increasing to 14% per annum if our gross margins fall below amounts specified in the Beedie Credit Agreement. Accrued interest on outstanding principal is payable monthly in arrears. We paid Beedie a commitment fee of $175,000 and will pay to Beedie a monthly standby fee of 0.325% on the unadvanced and available amount. Advances may be requested until July 25, 2020 and outstanding principal must be paid in full on January 25, 2021. Prepayment, which if at our option must be made in full and is otherwise required following certain asset dispositions, will be subject to a fee of 24 months accrued interest less all interest previously paid by the Company on the outstanding principal amount if paid prior to January 25, 2020. The initial minimum advance amount of $4,500,000 was advanced on January 26, 2018. Approximately $581,000 of the initial advance was used to repay Agility Capital to terminate the loan agreement between us and Agility dated March 11, 2016, as amended, and to release Agility Capital’s security interest in our assets. Approximately $1,074,000 of the initial advance was used to repay the 2017 Promissory Notes. The $175,000 commitment fee was capitalized asLess: deferred financing costs of which $14,583 and $38,888 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.

-(1,421,873)

Beedie Credit Agreement, net

-4,578,127

Total outstanding

$-$10,810,135

Less: deferred financing costs

-(1,522,740)

Total credit facility loans

$-$9,287,395

Short-term balance

$-$3,399,240

Long-term balance

-5,888,155

Total credit facility loans

$-$9,287,395


SAAS Capital Loan

On May 5, 2016, the Company entered into a loan and security agreement, or the SaaS Capital Loan, with SaaS Capital Funding II, LLC, or SaaS Capital, to borrow up to a maximum of $8,000,000. Initial amounts borrowed accrued interest at the rate of 10.25% per annum with future amounts borrowed bearing interest at the greater of 10.25% or 9.21% plus the three-year treasury rate at the time of advance. Accrued interest on amounts borrowed was payable monthly for the first six months and thereafter 36 equal monthly payments of principal and interest is payable. Prepayments were subject to a 10%, 6% or 3% of principal premium if prepaid prior to 12 months, between 12 and 24 months, or between 24 months and maturity, respectively.

The fair value of the warrants previously issued in connection with the SaaS Capital Loan were recorded as discounts to the notes payable and were being amortized into interest expense over the maturity periods. During the three months ended September 30, 2019 and 2018, $0 and $49,996, respectively, of debt discount was amortized into interest expense. During the nine months ended September 30, 2019 and 2018, $100,867 and $148,410, respectively, of debt discount was amortized into interest expense. At the time the outstanding loan balances were settled in June 2019, any remaining discount balances were recorded as interest expense.

On May 15, 2019, the Company entered into a consent letter, agreement and waiver of the SaaS Capital Loan to, among other things, provide that upon the closing of the Asset Purchase Agreement with Constellation, the Company will pay to SaaS Capital the outstanding principal balance and accrued but unpaid interest due under the SaaS Capital Loan plus $250,000 in fees, SaaS Capital will release its liens related to the Company’s CAKE Business assets, SaaS Capital’s warrants to purchase an aggregate of 1,733,333 shares of the Company’s common stock will be cancelled, and fees payable under the terms of the SaaS Capital Loan in the aggregate amount of $495,186 will be payable to SaaS Capital from the holdback and earnout payments payable by Constellation under the Asset Purchase Agreement in which the Company granted to SaaS Capital a security interest.

All amounts outstanding under the SaaS Capital Loan were paid in full on June 18, 2019 upon the closing of the Asset Purchase Agreement with Constellation. The total amount paid to satisfy the remaining obligation under the SaaS Capital Loan as of the closing date amounted to $4,576,123, consisting of the remaining principal balance outstanding of $4,252,209, as well as interest and fees of $323,914.

Beedie Credit Agreement

On January 25, 2018, the Company entered into a non-revolving term credit agreement, or the Beedie Credit Agreement, with Beedie Investments Limited, or Beedie, to borrow up to a maximum of $7,000,000. Outstanding principal will accrue interest at the rate of 12% per annum increasing to 14% per annum if the Company’s gross margins fall below amounts specified in the Beedie Credit Agreement. Accrued interest on outstanding principal was payable monthly in arrears. The Company paid Beedie a commitment fee of $175,000 and paid to Beedie a monthly standby fee of 0.325% on the unadvanced and available amount.

The fair value of the warrants previously issued in connection with the Beedie Credit Agreement were recorded as discounts to the notes payable and were being amortized into interest expense over the maturity periods. During the three months ended September 30, 2019 and 2018, $0 and $129,727, respectively, of debt discount was amortized into interest expense. During the nine months ended September 30, 2019 and 2018, $1,571,181 and $310,801, respectively, of debt discount was amortized into interest expense. At the time the outstanding loan balances were settled in June 2019, any remaining discount balances were recorded as interest expense.

On May 15, 2019, the Company entered into a seventh amendment of the Beedie Credit Agreement to, among other things, provide that upon the closing of the Asset Purchase Agreement with Constellation, the Company will pay to Beedie the outstanding principal balance and accrued but unpaid interest due under the Beedie Credit Agreement, Beedie will release its liens related to the Company’s CAKE Business assets, Beedie’s warrants to purchase an aggregate of 7,935,000 shares of the Company’s common stock will be cancelled, and fees payable under the terms of the Beedie Credit Agreement in the aggregate amount of $1,015,862 will be payable to Beedie from the holdback and earnout payments payable by Constellation under the Asset Purchase Agreement in which the Company granted to Beedie a security interest.

All amounts outstanding under the Beedie Credit Agreement were paid in full on June 18, 2019 upon the closing date of the Asset Purchase Agreement with Constellation. The total amount paid to satisfy the remaining obligation under the Beedie Credit Agreement as of the closing date amounted to $7,033,208, consisting of the remaining principal balance outstanding of $6,962,379, as well as interest and fees of $70,829.

 


 

The Beedie Credit Agreement contains customary covenants including, but not limited to, covenants to achieve specified adjusted EBITDA levels, to maintain minimum revenue renewal and liquidity levels, to maintain minimum gross margins, to maintain specified debt to monthly recurring revenue ratios, that limit capital expenditures and restrict our ability to pay dividends, purchase and sell assets outside[5]

A summary of the ordinary course, and that limit our ability to incur additional indebtedness. The occurrence of a material adverse change will be an event of defaultamounts previously outstanding under the Beedie Credit Agreement, in addition toCompany’s other customary events of default. Default interest will be charged at 18% per annum. We granted Beedie a security interest, subordinated to the security interest of SaaS Capital, in all of our assets through a pledge and security agreement, patent security agreement and trademark security agreement, each between us and Beedie. Beedie is entitled to board of director observation rights during the term of the Beedie Credit Agreement. long-term loans were as follows:

In connection with the Beedie Credit Agreement, we issued to Beedie a warrant to purchase up to 4,500,000

  

September 30,

  

December 31,

 
  

2019

  

2018

 
  

(Unaudited)

     
         

2018 Promissory Notes

 $-  $1,450,000 

August 2018 Promissory Notes

  -   1,500,000 

Less: deferred financing costs

  -   (676,598)

Other long-term loans, net

 $-  $2,273,402 
         
         

2018 Promissory Notes, related party

 $-  $550,000 

Less: deferred financing costs

  -   (163,314)
  $-  $386,686 

2018 Promissory Notes

On May 31, 2018, and June 15, 2018, the Company borrowed an aggregate of $2,000,000, respectively, from thirteen lenders, or the 2018 Lenders, and issued promissory notes, or the 2018 Promissory Notes, for the repayment of the amounts borrowed. The 2018 Lenders are all accredited investors, one of the 2018 Lenders is an affiliate of the Company’s director, Greg Akselrud, two of the 2018 Lenders are related to the Company’s Chairman and Chief Executive Officer, Brian Ross, and two of the 2018 Lenders are the Company’s employees. The 2018 Promissory Notes are unsecured, have a maturity date of May 30, 2021 and all principal is due upon maturity. Amounts borrowed accrue interest at 12% per annum and accrued interest is payable monthly. The Company also issued to the 2018 Lenders six-year warrants to purchase an aggregate of 3,000,000 shares of the Company’s Common Stock at an exercise price of $0.35 per share.

All amounts outstanding under the 2018 Promissory Notes were paid in full or settled through the exchange of outstanding amounts into Series A Preferred Stock on June 18, 2019 upon the closing of the Asset Purchase Agreement with Constellation. There was no gain or loss associated with this transaction.

August 2018 Promissory Notes

On August 31, 2018, the Company borrowed an aggregate of $1,500,000 from ten lenders, or the August 2018 Lenders and issued promissory notes, or the August 2018 Promissory Notes, for the repayment of the amounts borrowed. The August 2018 Lenders are all accredited investors. The August 2018 Promissory Notes are unsecured, have a maturity date of August 30, 2021 and all principal is due upon maturity. Amounts borrowed accrue interest at 12% per annum and accrued interest is payable monthly. The Company also issued to the August 2018 Lenders six-year warrants to purchase an aggregate of 1,500,000 shares of the Company’s common stock exercisable for cash at an exercise price of $0.35 per share.

All amounts outstanding under the August 2018 Promissory Notes were paid in full or settled through the exchange of outstanding amounts into Series A Preferred Stock on June 18, 2019 upon the closing of the Asset Purchase Agreement with Constellation. There was no gain or loss associated with this transaction.

The fair value of the warrants previously issued in connection with the 2018 Promissory Notes and the August 2018 Promissory Notes were recorded as discounts to the notes payable and were being amortized into interest expense over the maturity periods. During the three months ended September 30, 2019 and 2018, $0 and $69,124, respectively, of debt discount was amortized into interest expense. During the nine months ended September 30, 2019 and 2018, $839,912 and $89,602, respectively, of debt discount was amortized into interest expense. At the time the outstanding loan balances were settled in June 2019, any remaining discount balances were recorded as interest expense.


In accordance with the provisions of ASC 205-20, the Company has excluded the results of discontinued operations from its results of continuing operations in the accompanying unaudited condensed consolidated statements of operations. The results of the discontinued operations of the CAKE Business for the three and nine months ended September 30, 2019 and 2018 have been reflected as discontinued operations in the consolidated statements of operations, and consist of the following:

  

For the Three Months Ended

  

For the Nine Months Ended

 
  

September 30,

  

September 30,

  

September 30,

  

September 30,

 
  

2019

  

2018

  

2019

  

2018

 
                 
                 

Net revenues

 $-  $5,292,304  $9,001,307  $16,682,730 

Cost of revenue

  -   2,042,435   3,863,471   6,865,431 

Gross profit

  -   3,249,869   5,137,836   9,817,299 
                 

Operating expenses:

                

Research and development

  -   1,033,707   1,263,808   3,144,106 

Sales and marketing

  -   1,127,055   2,016,637   3,359,247 

General and administrative

  (1,113)  2,058,823   3,085,692   5,262,154 

Total operating expenses

  (1,113)  4,219,585   6,366,137   11,765,507 
                 

Loss from operations

  1,113   (969,716)  (1,228,301)  (1,948,208)
                 

Other income (expense):

                

Gain on sale of discontinued operations

  -   -   19,473,080   - 

Interest income

  -   (247)  34   503 

Interest expense

  -   (679,663)  (3,773,651)  (1,819,628)

Total other income (expense)

  -   (679,910)  15,699,463   (1,819,125)
                 

Net income (loss) from discontinued operations before provision for income taxes

  1,113   (1,649,626)  14,471,162   (3,767,333)

Provision for (benefit from) income taxes

  -   -   -   - 

Net income (loss) from discontinued operations

 $1,113  $(1,649,626) $14,471,162  $(3,767,333)

The following is a summary of the gain on sale of discontinued operations of the CAKE Business reflected above during the nine months ended September 30, 2019.

Gross proceeds received

 $20,892,667 
     

Less: value of net assets sold

    
     

Accounts receivable

  1,979,342 

Prepaid and other current assets

  51,363 

Property and equipment

  20,986 

ROU lease asset

  1,458,922 

Other assets

  39,702 

Accounts payable and accrued expenses

  (344,787)

Deferred revenue

  (138,112)

ROU lease liability

  (1,612,412)

Other liabilities

  (35,417)

Total net assets sold

  1,419,587 

Gain on sale of CAKE Business

 $19,473,080 


NOTE 8: COMMITMENTS AND CONTINGENCIES

On June 20, 2019, the Company entered into a Lease Agreement with Emerging Growth, LLC for the lease of office space in Whitefish, Montana, for a period of one year at a rate of $1,500 per month. Management has elected a policy to exclude leases with an initial term of 12 months or less from the balance sheet presentation required under ASC 842. As a result, the office lease has been excluded from balance sheet presentation as it has an original term of 12 months or less.   

The Company leases office space in Santa Monica, California, under a short-term lease expiring on July 31, 2019 for $1,000 per month. The Company has renewed the terms of the lease for a period of one year through July 31, 2020.

During August 2017, the Company entered into an amendment to its original January 2014 lease for certain office space in Newport Beach.  Pursuant to the lease amendment, effective March 1, 2018, the premises shall be expanded to include an additional 1,332 usable square feet such that the premises shall consist of 11,728 usable square feet in the aggregate. In addition, pursuant to the terms of the lease amendment, the Company extended the term of the lease agreement until June 30, 2023. Commencing on March 1, 2018, the initial base rent for the premises will be $38,702 per month for the first year and increasing to $44,566 per month by the end of the term. This lease was transferred to Constellation upon the sale of the CAKE Business that closed on June 18, 2019. The Company has no further obligations under this lease.

During July 2014, the Company entered into a five-year lease for certain office space in a business center in London, England, which commenced on July 30, 2014. The base rent is GBP 89,667 (approximately $115,000) per year and the estimated service charges for the lease are GBP 45,658 (approximately $56,000) per year. This lease expired on July 30, 2019. The Company has discontinued its operations associated with the CAKE Business it conducted at the Subsidiary in London and has vacated the office upon the expiration of the lease.

Legal Proceedings

From time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently a party to any legal proceedings that it currently believes, if determined adversely to the Company, would individually or taken together have a material adverse effect on the Company’s business, operating results, financial condition or cash flows.

NOTE 9: SUBSEQUENT EVENTS

Effective October 22, 2019, the Company filed a certificate of amendment with the Secretary of State of the State of Delaware pursuant to which the corporate name was changed from Accelerize Inc. to CFN Enterprises Inc. In connection with the name change, the trading symbol of CFN Enterprises Inc. on the OTCQB was changed from ALCZ to CNFN with the symbol change effective on October 24, 2019. 

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with the financial statements and related notes included elsewhere in this report and our Annual Report on Form 10-K for the year ended December 31, 2018. Certain statements in this discussion and elsewhere in this report constitute forward-looking statements. See “Cautionary Statement Regarding Forward Looking Information’’ elsewhere in this report. Because this discussion involves risk and uncertainties, our actual results may differ materially from those anticipated in these forward-looking statements.

Overview

We owned and operated CAKE and getcake.com, a marketing technology company that provided a proprietary solution for advanced analytics, attribution and campaign optimization for digital marketers, and we sold this business on June 18, 2019. We contemporaneously acquired assets from Emerging Growth LLC related to its cannabis industry focused sponsored content and marketing business, or the CFN Business. Our initial ongoing operations will consist primarily of the CFN Business and we will continue to pursue strategic transactions and opportunities.


The CFN Business generates revenue through sponsored content, including articles, press releases, videos, podcasts, advertisements and other media, email advertisements and other marketing campaigns run on behalf of public and private companies in the cannabis industry, helping them reach accredited, retail and institutional investors. Most revenue is generated through contracts involving a monthly cash payment.

The CFN Business’ primary expenses come from advertising on platforms like Twitter and Facebook and from employee salaries and contractor fees. The CFN Business’ content is primarily produced by a team of freelance writers and video content is produced through various vendors. The CFN Business also incurs hosting and development costs associated with maintaining and improving its website, web applications, and mobile applications. The CFN Business operates several media platforms, including CannabisFN.com, the CannabisFN iOS app, the CFN Media YouTube channel, the CFN Media podcast, and other venues. These properties are designed to educate and inform investors interested in the cannabis industry, as well as provide a platform for the clients of the CFN Business to reach investors. The CFN Business distributes content across numerous online platforms, including the CannabisFN.com website, press releases, financial news syndicates, search engines, YouTube, iTunes, Twitter, Instagram, Facebook, LinkedIn, and others.

The CFN Business targets the legal cannabis industry. According to Grand View Research, the global cannabis industry is expected to reach $146.4 billion by 2025, driven by the legalization of medical and adult-use cannabis across a growing number of jurisdictions. According to the Marijuana Index, there are approximately 400 public companies involved in the cannabis industry, which represents the primary target market of the CFN Business. The CFN Business’ services are designed to help private companies prepare to go public and public companies grow their shareholder base through sponsored content and marketing outreach. The success of the CFN Business depends on the legal status of cannabis, investor demand for cannabis investments, and numerous other external factors.

The CFN Business competes with other public relations firms for clients, as well as online publishers for investors. Public relations competition includes investor awareness firms like Stockhouse Publishing, Catalyst Xchange, Stonebridge Partners and Midan Ventures. Online publisher competition includes firms like New Cannabis Ventures, Leafly and High Times. The CFN Business is regulated by rules established by the SEC, FINRA, and certain federal and state cannabis regulations.

Our principal offices are located at 2601 Ocean Park Boulevard, Suite 310, Santa Monica, California 90405. Our telephone number there is: (310) 314-8804. Our corporate website is: www.cfnenterprisesinc.com, the contents of which are not part of this quarterly report.

Our Common Stock is quoted on the OTCQB Marketplace under the symbol "CNFN." 


Results of Operations for the Three Months Ended September 30, 2019 and 2018

The following are the results of our operations for the three months ended September 30, 2019 as compared to the three months ended September 30, 2018:

  

For the Three Months Ended

     
  

September 30,

  

September 30,

     
  

2019

  

2018

  

Change

 
             
             

Net revenues

 $568,992  $-  $568,992 

Cost of revenue

  381,277   -   381,277 

Gross profit

  187,715   -   187,715 
             

Operating expenses:

            

Selling, general and administrative

  600,663   313,536   287,127 

Total operating expenses

  600,663   313,536   287,127 
             

Loss from operations

  (412,948)  (313,536)  (99,412)
             

Other income (expense):

            

Interest expense

  (2,514)  -   (2,514)

Interest income

  19   25   (6)

Total other income (expense)

  (2,495)  25   (2,520)
             

Net loss before provision for income taxes

  (415,443)  (313,511)  (101,932)

Provision for income taxes

  -   -   - 

Net loss from continuing operations

  (415,443)  (313,511)  (101,932)

Gain (loss) from discontinued operations, net of tax

  1,113   (1,649,626)  1,650,739 

Net loss

 $(414,330) $(1,963,137) $1,548,807 

Net Revenues

Subsequent to the closing of the Asset Purchase Agreement with Constellation on June 18, 2019, which resulted in the sale of our CAKE Business and discontinuation of our operations previously recorded under this line of business, our net revenues from continuing operations consists of revenue generated from customer contracts acquired in the Emerging Growth Agreement which closed on June 20, 2019. Subsequent to this date, our revenues are generated from the sale of promotional service packages to customers ranging from 3 to 6 months. We offer different packages tailored to the type and stage of the potential customer, such as public companies looking to increase their shareholder base, as well as private companies potentially looking to go public and attract capital and publicity. Our revenue for the three months ended September 30, 2019 represents revenue related to this line of business. We expect this be our primary source of revenue going forward.

Costs of Revenue

Our cost of revenue represents costs incurred associated with performing services under our customer contracts acquired under the Emerging Growth Agreement. Our cost of revenue for the three months ended September 30, 2019 related to this line of business. We expect for our cost of revenue to increase proportionately with increases in revenues recognized in future periods.

Operating Expenses

Our operating expenses for the three months ended September 30, 2019 increased by $287,127 as compared to the prior year period due primarily to additional legal and professional fees associated with regulatory requirements during 2019 associated with the Asset Purchase Agreement and the Emerging Growth Agreement. Continuing operating expenses presented during the three months ended September 30, 2018 reflect administrative expenses associated with business insurance, legal and accounting fees that we will continue to incur.

Discontinued Operations

Effective June 18, 2019, we sold substantially all of our assets associated with the CAKE Business for total proceeds of $20,892,667. During the three months ended September 30, 2019, we had a small gain from discontinued operations of $1,113 due to adjustments made to certain accrued liabilities associated with our Subsidiary. The loss from discontinued operations during the three months ended September 30, 2018 represents the prior year results from the CAKE Business reclassified as discontinued operations.


Results of Operations for the Nine Months Ended September 30, 2019 and 2018

The following are the results of our operations for the nine months ended September 30, 2019 as compared to the nine months ended September 30, 2018:

  

For the Nine Months Ended

     
  

September 30,

  

September 30,

     
  

2019

  

2018

  

Change

 
             
             

Net revenues

 $631,712  $-  $631,712 

Cost of revenue

  414,726   -   414,726 

Gross profit

  216,986   -   216,986 
             

Operating expenses:

            

Selling, general and administrative

  1,495,492   1,016,368   479,124 

Total operating expenses

  1,495,492   1,016,368   479,124 
             

Loss from operations

  (1,278,506)  (1,016,368)  (262,138)
             

Other income (expense):

            

Interest expense

  (2,514)  -   (2,514)

Interest income

  131   61   70 

Total other income (expense)

  (2,383)  61   (2,444)
             

Net loss before provision for income taxes

  (1,280,889)  (1,016,307)  (264,582)

Provision for income taxes

  -   -   - 

Net loss from continuing operations

  (1,280,889)  (1,016,307)  (264,582)

Gain (loss) from discontinued operations, net of tax

  14,471,162   (3,767,333)  18,238,495 

Net income (loss)

 $13,190,273  $(4,783,640) $17,973,913 

Net Revenues

Subsequent to the closing of the Asset Purchase Agreement with Constellation on June 18, 2019, which resulted in the sale of our CAKE Business and discontinuation of our operations previously recorded under this line of business, our net revenues consist of revenue generated from customer contracts acquired in the Emerging Growth Agreement which closed on June 20, 2019. Subsequent to this date, our revenues are generated from the sale of promotional service packages to customers ranging from 3 to 6 months. We offer different packages tailored to the type and stage of the potential customer, such as public companies looking to increase their shareholder base, as well as private companies potentially looking to go public and attract capital and publicity. Our revenue for the nine months ended September 30, 2019 represents revenue recognized for the period from June 21, 2019 through September 30, 2019. We expect this be our primary source of revenue going forward.

Costs of Revenue

Our cost of revenue represents costs incurred associated with performing services under our customer contracts acquired under the Emerging Growth Agreement. Our cost of revenue for the nine months ended September 30, 2019 represents revenue recognized for the period from June 21, 2019 through September 30, 2019. We expect for our cost of revenue to increase proportionately with increases in revenues recognized in future periods.

Operating Expenses

Our operating expenses for the nine months ended September 30, 2019 increased by $479,124 as compared to the prior year period due primarily to additional legal and professional fees associated with the closing of the Asset Purcahse Agreement and the Emerging Growth Agreement and the reporting regulatory requirements associated with these transactions. Continuing operating expenses presented during the nine months ended September 30, 2018 reflect administrative expenses associated with business insurance, legal and accounting fees that we will continue to incur.


Discontinued Operations

Effective June 18, 2019, we sold substantially all of our assets associated with the CAKE Business for total proceeds of $20,892,667. Accordingly, we had a gain from discontinued operations during the nine months ended September 30, 2019 of $14,471,162, which includes the gain on sale of the CAKE Business of $19,473,080 offset by losses from the CAKE business through June 18, 2019. The loss from discontinued operations during the nine months ended September 30, 2018 represents the prior year results from the CAKE Business reclassified as discontinued operations.

Liquidity and Capital Resources

On May 15, 2019, we entered into the Asset Purchase Agreement to sell substantially all of our assets related to the CAKE Business. We received gross cash proceeds of $20,892,667 for the sale of this business, less payments totaling $20,190,869 for the payoff of existing debt, transaction costs, and certain vendor payables, leaving us with a net increase to cash of $701,798. Concurrent with this agreement, we also entered into the Emerging Growth Agreement where we acquired certain assets from Emerging Growth, LLC related to its sponsored content and marketing business for purchase price consideration consisting in part of $420,000 in cash. In September 2019, we received proceeds of $500,000 from a note payable. Our plan to continue as a going concern includes raising additional capital in the form of debt or equity, growing the business acquired under the Emerging Growth Agreement and managing and reducing operating and overhead costs. We cannot provide any assurance that unforeseen circumstances that could occur at any time within the next twelve months or thereafter will not increase the need for us to raise additional capital on an immediate basis.

These matters, among others, raise substantial doubt about our ability to continue as a going concern. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should we be unable to continue as a going concern.

The following is a summary of our cash flows from operating, investing and financing activities for the nine months ended September 30, 2019 and 2018.

  

Nine Months Ended

 
  

September 30,

  

September 30,

 
  

2019

  

2018

 

Cash flows used in operating activities

 $(6,153,982) $(2,769,540)

Cash flows provided by (used in) investing activities

 $20,470,916  $(1,155,829)

Cash flows provided by (used in) financing activities

 $(13,407,514) $5,587,198 

As of September 30, 2019, we had unrestricted cash of $975,434.

Net cash used in operating activities was approximately $6.2 million during the nine months ended September 30, 2019, compared with approximately $2.8 million during the same period in 2018. The increase in cash used in operating activities was primarily due to a decrease in accounts payable and accrued expenses due to a large number of liabilities being paid at the time of closing of the Asset Purchase Agreement on June 18, 2019, as well as a higher loss from continuing activities during 2019.

Net cash provided by investing activities amounted to approximately $20.5 million during the nine months ended September 30, 2019, compared with cash used in investing activities of approximately $1.2 million during the same period in 2018. Cash provided by investing activities in 2019 consisted primarily of proceeds from the sale of the CAKE Business of approximately $20.9 million, offset by cash used of $420,000 for the acquisition of assets pursuant to the Emerging Growth Agreement. During the nine months ended September 30, 2018, our cash used in investing activities consisted primarily of expenditures for software capitalized for internal use. These expenditures related to the discontinued operations of the CAKE Business and will not be recurring.


Net cash used in financing activities was approximately $13.4 million for the nine months ended September 30, 2019, compared to net cash provided by financing activities of approximately $5.6 million for the same period in 2018. Cash used in financing activities in 2019 consisted of payments of approximately $11.8 million to repay the principal amounts outstanding under our credit facilities, repayment of promissory notes of $2.7 million and repayment of related party notes of $300,000. These repayments occurred at the time of closing of the Asset Purchase Agreement on June 18, 2019 for the sale of the CAKE Business. The cash used in financing activities in 2019 was offset by proceeds from credit facility borrowings of $900,000, as well as proceeds of $500,000 from a note payable in September 2019. During the nine months ended September 30, 2018, our cash provided by financing activities was approximately $5.6 million, which consisted of proceeds from borrowings under the credit facility of approximately $5.5 million and borrowings under promissory notes of $3.5 million, offset by repayments of principal under the credit facility of approximately $2.4 million and repayments of promissory notes of $1 million.

Description of Indebtedness

As of June 18, 2019, upon the closing of the Asset Purchase Agreement for the sale of the CAKE Business, all existing debt at the time was either paid off or settled through the exchange of outstanding principal into Series A Preferred Stock.

On September 10, 2019, we entered into a promissory note payable whereby we borrowed $500,000 bearing interest at 8% per annum. Interest on the note is payable quarterly on the first business day of December, March, June and September commencing December 1, 2019. Outstanding principal on the note is due in full on September 30, 2022.

In connection with the promissory note payable on September 10, 2019, we issued warrants to purchase 500,000 shares of the Company’s common stock at an exercise price of $0.10 per share. The warrants expire on September 10, 2024 and are fully vested upon issuance. The note was discounted by $17,624 allocated from the valuation of the warrants issued. The discount recorded on the note is being amortized as interest expense through the maturity date, which amounted to $322 for the three and nine months ended September 30, 2019. As of September 30, 2019, the net book value of the promissory note amounted to $482,698 including the principal amount outstanding of $500,000 net of the remaining discount of $17,302.

The following is a summary of our outstanding debt prior to the closing of the Asset Purchase Agreement on June 18, 2019, and the related transactions during the nine months ended September 30, 2019.

SAAS Capital Loan

On May 5, 2016, we entered into the SaaS Capital Loan with SaaS Capital to borrow up to a maximum of $8,000,000. Initial amounts borrowed accrued interest at the rate of 10.25% per annum with future amounts borrowed bearing interest at the greater of 10.25% or 9.21% plus the three-year treasury rate at the time of advance. Accrued interest on amounts borrowed was payable monthly for the first six months and thereafter 36 equal monthly payments of principal and interest is payable. Prepayments will be subject to a 10%, 6% or 3% of principal premium if prepaid prior to 12 months, between 12 and 24 months, or between 24 months and maturity, respectively.

The fair value of the warrants previously issued in connection with the SaaS Capital Loan were recorded as discounts to the notes payable and were being amortized into interest expense over the maturity periods. During the three months ended September 30, 2019 and 2018, $0 and $49,996, respectively, of debt discount was amortized into interest expense. During the nine months ended September 30, 2019 and 2018, $100,867 and $148,410, respectively, of debt discount was amortized into interest expense. At the time the outstanding loan balances were settled in June 2019, any remaining discount balances were recorded as interest expense.

On May 15, 2019, we entered into a consent letter, agreement and waiver of the SaaS Capital Loan to, among other things, provide that upon the closing of the Asset Purchase Agreement with Constellation, we will pay to SaaS Capital the outstanding principal balance and accrued but unpaid interest due under the SaaS Capital Loan plus $250,000 in fees, SaaS Capital will release its liens related to our CAKE Business assets, SaaS Capital’s warrants to purchase an aggregate of 1,733,333 shares of our common stock will be cancelled, and fees payable under the terms of the SaaS Capital Loan in the aggregate amount of $495,186 will be payable to SaaS Capital from the holdback and earnout payments payable by Constellation under the Asset Purchase Agreement in which we granted SaaS Capital a security interest.


All amounts outstanding under the SAAS Credit Loan were paid in full on July 18, 2019 upon the closing date of the Asset Purchase Agreement with Constellation. The total amount paid to satisfy the remaining obligation under the SaaS Capital Loan as of the closing date amounted to $4,576,123, consisting of the remaining principal balance outstanding of $4,252,209, as well as interest and fees of $323,914.

Beedie Credit Agreement

On January 25, 2018, we entered into the Beedie Credit Agreement with Beedie to borrow up to a maximum of $7,000,000. Outstanding principal accrued interest at the rate of 12% per annum increasing to 14% per annum if our gross margins fall below amounts specified in the Beedie Credit Agreement. Accrued interest on outstanding principal was payable monthly in arrears. We paid Beedie a commitment fee of $175,000 and paid to Beedie a monthly standby fee of 0.325% on the unadvanced and available amount.

The fair value of the warrants previously issued in connection with the Beedie Credit Agreement were recorded as discounts to the notes payable and were being amortized into interest expense over the maturity periods. During the three months ended September 30, 2019 and 2018, $0 and $129,727, respectively, of debt discount was amortized into interest expense. During the nine months ended September 30, 2019 and 2018, $1,571,181 and $310,801, respectively, of debt discount was amortized into interest expense. At the time the outstanding loan balances were settled in June 2019, any remaining discount balances were recorded as interest expense.

On May 15, 2019, we entered into a seventh amendment of the Beedie Credit Agreement to, among other things, provide that upon the closing of the Asset Purchase Agreement with Constellation, we will pay to Beedie the outstanding principal balance and accrued but unpaid interest due under the Beedie Credit Agreement, Beedie will release its liens related to our CAKE Business assets, Beedie’s warrants to purchase an aggregate of 7,935,000 shares of our common stock will be cancelled, and fees payable under the terms of the Beedie Credit Agreement in the aggregate amount of $1,015,862 will be payable to Beedie from the holdback and earnout payments payable by Constellation under the Asset Purchase Agreement in which we granted Beedie a security interest.

All amounts outstanding under the Beedie Credit Agreement were paid in full on July 18, 2019 upon the closing date of the Asset Purchase Agreement with Constellation. The total amount paid to satisfy the remaining obligation under the Beedie Credit Agreement as of the closing date amounted to $7,033,208, consisting of the remaining principal balance outstanding of $6,962,379, as well as interest and fees of $70,829.

2018 Promissory Notes

On May 31, 2018, and June 15, 2018, we borrowed an aggregate of $2,000,000, respectively, from the 2018 Lenders and the 2018 Promissory Notes for the repayment of the amounts borrowed. The 2018 Lenders were all accredited investors, one of the 2018 Lenders is an affiliate of our director, Greg Akselrud, two of the 2018 Lenders are related to our Chairman and Chief Executive Officer, Brian Ross, and two of the 2018 Lenders were our employees. The 2018 Promissory Notes were unsecured, had a maturity date of May 30, 2021 and all principal is due upon maturity. Amounts borrowed accrued interest at 12% per annum and accrued interest was payable monthly. We also issued to the 2018 Lenders six-year warrants to purchase an aggregate of 3,000,000 shares of our common stock at an exercise price of $0.35 per share.

All amounts outstanding under the 2018 Promissory Notes were paid in full or settled through the exchange of outstanding amounts into Series A Preferred Stock on July 18, 2019 upon the closing of the Asset Purchase Agreement with Constellation.


August 2018 Promissory Notes

On August 31, 2018, we borrowed an aggregate of $1,500,000 from the August 2018 Lenders and issued the August 2018 Promissory Notes for the repayment of the amounts borrowed. The August 2018 Lenders were all accredited investors. The August 2018 Promissory Notes were unsecured, had a maturity date of August 30, 2021 and all principal was due upon maturity. Amounts borrowed accrued interest at 12% per annum and accrued interest was payable monthly. We also issued to the August 2018 Lenders six-year warrants to purchase an aggregate of 1,500,000 shares of our common stock exercisable for cash at an exercise price of $0.35 per share.

All amounts outstanding under the August 2018 Promissory Notes were paid in full or settled through the exchange of outstanding amounts into Series A Preferred Stock on July 18, 2019 upon the closing of the Asset Purchase Agreement with Constellation.

The fair value of the warrants previously issued in connection with the 2018 Promissory Notes and the August 2018 Promissory Notes were recorded as discounts to the notes payable and were being amortized into interest expense over the maturity periods. During the three months ended September 30, 2019 and 2018, $0 and $69,124, respectively, of debt discount was amortized into interest expense. During the nine months ended September 30, 2019 and 2018, $839,912 and $89,602, respectively, of debt discount was amortized into interest expense. At the time the outstanding loan balances were settled in June 2019, any remaining discount balances were recorded as interest expense.

Obligations Under Preferred Stock

On June 20, 2019, existing debtholders with outstanding principal balances totaling $500,000 from the above 2018 Promissory Notes and August 2018 Promissory Notes were issued an aggregate of 500 shares of Series A Preferred Stock, each with a stated value per share of $1,000, as conversion of $500,000 worth of outstanding promissory notes. The Series A Preferred Stock bears interest at 12% per annum, and is convertible into our common stock at the election of the holder at a conversion price per share to be mutually agreed between us and the holder in the future, and be redeemable at our option following the third year after issuance, without voting rights or a liquidation preference.

On June 20, 2019, we issued 3,000 shares of Series B Preferred Stock, each with a stated value of $1,000 per share, to Emerging Growth, LLC as part of the Emerging Growth Agreement. The aggregate fair value of $687,000 was recorded as part of the acquisition price of the net assets acquired from Emerging Growth, LLC. The Series B Preferred Stock bears interest at 6% per annum and is convertible into our common stock at the election of Emerging Growth, LLC at a conversion price per share to be mutually agreed between us and Emerging Growth, LLC in the future, without voting rights or a liquidation preference, except with respect to accrued penalty interest.

Other outstanding obligations at September 30, 2019

Warrants

As of September 30, 2019, 8,127,184 shares of our common stock are issuable pursuant to the exercise of warrants.

Options

As of September 30, 2019, 6,595,000 shares of our common stock at an exercise price of $0.35 per share subject to certain adjustments for dividends, splits or reclassifications, and a weighted average adjustment for certain issuances of common stock below the exercise price prior to January 26, 2019. Up to 2,500,000 additional shares of common stock under the Beedie Warrant will be exercisable on a pro rata basis to additional amounts borrowed if and when advanced under the Beedie Credit Agreement. We adopted ASU 2017-11 which revises ASC 815-10-15-74 to allow instruments with a down round features to qualify for equity classification. Under the new guidance, the issuer would recognize the value of the feature only when it is activated and there is an actual reduction of the strike price or conversion feature.  The value of the adjustment is then to be recorded as deemed dividend and a reduction of income available to common stockholders. The fair value of the warrant amounted to $1,099,861 and was capitalized as deferred financing costs, of which $91,655 and $244,413 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.

On May 31, 2018, we entered into the First Beedie Amendment to permit the issuance of the 2018 Promissory Notes, to amend our adjusted EBITDA, revenue renewal and total debt to monthly recurring revenue covenants, and to add a secured debt to monthly recurring revenue covenant. In addition, we issued to Beedie a warrant to purchase up to 500,000 shares of our common stock at an exercise price of $0.35 per share subject to certain adjustments for dividends, splits or reclassifications, and a weighted average adjustment for certain issuances of common stock below the exercise price prior to January 25, 2019. This arrangement was treated as a normal modification of existing debt pursuant to the guidance of ASC 470-50 “Debt – Modifications and Extinguishments” (ASC 470-50). Because the net present value of the modified notes was lesser than 10% of the present value of the remaining cash flows under the old debt, the transaction was treated as a debt modification. The fair value of the warrant amounted to $120,330 and was capitalized as deferred financing costs, of which $10,027 and $13,370 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.

On June 13, 2018, we entered into the Second Beedie Amendment to issue additional 2018 Promissory Notes. In addition, we issued to Beedie a warrant to purchase up to 100,000 shares of our common stock at an exercise price of $0.35 per share subject to certain adjustments for dividends, splits or reclassifications, and a weighted average adjustment for certain issuances of common stock below the exercise price prior to January 25, 2019. This arrangement was treated as a normal modification of existing debt pursuant to the guidance of ASC 470-50 “Debt – Modifications and Extinguishments” (ASC 470-50). Because the net present value of the modified notes was lesser than 10% of the present value of the remaining cash flows under the old debt, the transaction was treated as a debt modification. The fair value of the warrant amounted to $24,053 and was capitalized as deferred financing costs, of which $2,004 and $2,672 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.

On August 31, 2018, we entered into the Third Beedie Amendment to borrow the second tranche of the term loan facility in the amount of $1,500,000, to permit the issuance of the August 2018 Promissory Notes, to amend the commitment fee, to amend our minimum adjusted EBITDA, revenue renewal, total debt to monthly recurring revenue and secured debt to monthly recurring revenue covenants and to provide for twice monthly reporting of our projected cash flows. In connection with the Third Beedie Amendment, we issued to Beedie a warrant to purchase up to 1,500,000 shares of our common stock and a warrant to purchase up to an additional 835,000 shares of our common stock at an exercise price of $0.35 per share subject to certain adjustments for dividends, splits or reclassifications, and a weighted average adjustment for certain issuances of common stock below the exercise price prior to January 25, 2019. The fair value of these warrants amounted to $412,484 and was capitalized as deferred financing costs, of which $11,458 and $11,458 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.

2018 Promissory Notes

On May 31, 2018, and June 15, 2018, we borrowed an aggregate of $1,500,000 and $500,000, respectively, from the 2018 Lenders, and issued the 2018 Promissory Notes for the repayment of the amounts borrowed. The 2018 Lenders are all accredited investors, one of the 2018 Lenders is an affiliate of our director, Greg Akselrud, one of the 2018 Lenders is an affiliate of our Chief Financial Officer, Anthony Mazzarella, two of the 2018 Lenders are related to our Chairman and Chief Executive Officer, Brian Ross, and two of the 2018 Lenders are employees of ours. The 2018 Promissory Notes are unsecured, have a maturity date of May 30, 2021 and all principal is due upon maturity. Amounts borrowed accrue interest at 12% per annum and accrued interest is payable monthly. We also issued to the 2018 Lenders six-year warrants to purchase an aggregate of 3,000,000 shares of our Common Stock at an exercise price of $0.35 per share. The fair value of the warrants amounted to $737,218 and was capitalized as deferred financing costs, of which $61,435 and $81,913 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.

August 2018 Promissory Notes

On August 31, 2018, we borrowed an aggregate of $1,500,000, from the August 2018 Lenders, and issued promissory notes for the repayment of the amounts borrowed. The August 2018 Lenders are all accredited investors. The August 2018 Promissory Notes are unsecured, have a maturity date of August 30, 2021 and all principal is due upon maturity. Amounts borrowed accrue interest at 12% per annum and accrued interest is payable monthly. We also issued to the Lenders six-year warrants to purchase an aggregate of 1,500,000 shares of our common stock exercisable for cash at an exercise price of $0.35 per share. The fair value of the warrants amounted to $276,798 and was capitalized as deferred financing costs, of which $7,689 and $7,689 was expensed during the three and nine-month periods ended September 30, 2018, respectively, and $0 during 2017.


Changes in Cash Flows

  

Nine-month periods ended

September 30,

 
  

2018

  

2017

 

Cash flows from operating activities:

        

Net loss

 $(4,783,640

)

 $(1,367,678

)

Adjustments to reconcile net loss to net cash used in operating activities:

        

Depreciation and amortization

  461,893   612,639 

Amortization of debt discount and deferred financing cost

  636,125   180,204 

Provision for bad debt

  (202,221

)

  (48,586

)

Fair value of options and warrants

  342,698   633,997 

Loss on sale of fixed assets

  997   902 

Changes in operating assets and liabilities:

        

Accounts receivable

  764,381   (196,315

)

Prepaid expenses and other assets

  147,888   (129,077

)

Accounts payable and accrued expenses

  (415,072

)

  (641,049

)

Deferred revenues

  264,065   18,213 

Other assets

  13,346   (20,016

)

Net cash used in operating activities

  (2,769,540

)

  (956,766

)

         

Cash flows from investing activities:

        

Capitalized software for internal use

  (1,125,000

)

  (1,347,075

)

Capital expenditures

  (31,579

)

  (44,125

)

Proceeds from sale of assets

  750   795 

Net cash used in investing activities

  (1,155,829

)

  (1,390,405

)

         

Cash flows from financing activities:

        

Principal repayments of credit facility and loan

  (2,402,652

)

  (1,653,282

)

Proceeds from credit facility

  5,489,850   1,923,000 

Proceeds from promissory notes

  3,500,000   1,000,000 
Repayments of promissory notes  (1,000,000)  - 

Net cash provided by financing activities

  5,587,198   1,269,718 
         

Effect of exchange rate changes on cash

  (20,683

)

  32,098 
         

Net increase (decrease) in cash

  1,641,146   (1,045,355

)

         

Cash, beginning of period

  216,883   1,730,127 
         

Cash, end of period

 $1,858,029  $684,772 

Changes in Cash Flows During the Nine Months ended September 30, 2018

As of September 30, 2018, we had cash of approximately $1,860,000.

Net cash used in operating activities was approximately $2,770,000 during the nine-month period ended September 30, 2018 compared to net cash used in operations of approximately $957,000 during the same period in 2017. The change in operating cash flow was primarily due to a decrease in accounts payable and accrued expenses.

Net cash used in investing activities was approximately $1,155,000 during the nine-month period ended September 30, 2018 compared to $1,390,000 for the same period in 2017. The decrease in capitalization of development costs for internal-use software of approximately $220,000 and a decrease in capital expenditures of approximately $30,000 accounted for the decrease in cash used in investing activities.

Net cash provided by financing activities was approximately $5,590,000 for the nine-month period ended September 30, 2018 compared to $1,270,000 for the same period in 2017. The increase in cash provided by financing activities was due to approximately $5,600,000 in higher proceeds from our credit facility and promissory notes during the nine-month period ended September 30, 2018 when compared to the same period in 2017, offset with higher credit facility principal payments of approximately $1,300,000. 


Exercise of warrants

There were no proceeds generated from the exercise of warrants during the nine-month period ended September 30, 2018.

Other outstanding obligations at September 30, 2018

Warrants

As of September 30, 2018, 25,045,517 shares of our Common Stock are issuable pursuant to the exercise of warrants.

Options

As of September 30, 2018, 7,237,500 shares of our Common Stock are issuable pursuant to the exercise of options.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.


 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer, who is our principal executive officer and our Chief Financial Officer, who is our principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act.amended. Based upon that evaluation, our principal executive officer and principal financial officer concluded that as of September 30, 2018,2019, our disclosure controls and procedures are effective in ensuring that material information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, including ensuring that such material information is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.were effective.

Changes in Internal Control Over Financial Reporting

 

During the quarter ended September 30, 2018, there were no changes2019, in order to remediate the segregation of duties and other deficiencies initially created by the departure of our accounting department in June 2019, we hired an outside bookkeeper and accounting consultants to perform our account reconciliations and other day-to-day accounting requirements. The internal control overstructure was also documented and assessed in the areas of financial reporting and disclosure controls as it relates to our continuing operations. In addition, we revised and improved the use of our systems for getting appropriate approvals for purchases and other activities that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.require authorization.

 

PART II - OTHER INFORMATION

 

Item 1A. Risk Factors.

Except as set forth below, there have been no material changes to the Risk Factors set forth in our annual report on Form 10-K filed with the SEC on March 27, 2018.

Our pursuit of strategic transactions could disrupt our business, cause dilution to our stockholders and otherwise harm our business.

We may pursue strategic transactions such as acquisitions and dispositions as well as pursue strategic alliances, joint ventures, technology licenses or investments in complementary businesses. We have limited experience with respect to these types of strategic transactions. Any of these transactions could be material to our financial condition and operating results and expose us to many risks, including:

disruption in our relationships with customers, distributors or suppliers as a result of such a transaction;

unanticipated liabilities related to acquired companies;

difficulties integrating acquired personnel, technologies and operations into our existing business;


diversion of management time and focus from operating our business to acquisition integration or disposal challenges;

increases in our expenses and reductions in our cash available for operations and other uses; and

possible write-offs or impairment charges relating to acquired businesses.

We may not be successful in pursing strategic transactions. The anticipated benefit of any strategic transaction may not materialize. Future strategic transactions such as acquisitions or dispositions could result in potentially dilutive issuances of our equity securities, the incurrence of debt, contingent liabilities or amortization expenses or write-offs of goodwill, any of which could harm our financial condition. We cannot predict the number, timing or size of future strategic transactions, or the effect that any such transactions might have on our operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On July 1, 2018, we issued 120,000 restricted shares of our Common Stock, vesting in 4 equal quarterly increments commencing on July 1, 2018, to each of our non-employee directors as partial annual compensation for services as a director. These issuances are exempt from registration pursuant to Section 4(a)(2) under the Securities Act of 1933, as amended, or the Securities Act, as not involving any public offering.

On August 13, 2018, we issued  warrants to purchase up to an aggregate of 1,000,000 shares of our Common Stock to two employees. The warrants are exercisable in cash or on a cashless basis at an exercise price of $0.50 per share, vest in twelve equal quarterly amounts, and expire on August 13, 2023.  These issuances are exempt from registration pursuant to Section 4(a)(2) under the Securities Act as not involving any public offering.

Item 6.  Exhibits

 

3.1

Composite Copy of Certificate of Incorporation, as amended as of October 22, 2019.*

3.2

Composite Copy of Certificate of Incorporation, as amended as of October 22, 2019 (marked copy).*

4.1

Form of Warrant issued on August 31, 2018September 12, 2019 (incorporated by reference to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 5, 2018)18, 2019).

4.210.1

Form of WarrantPromissory Note issued on August 31, 2018September 12, 2019 (incorporated by reference to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 5, 2018)18, 2019).

10.1

Form of Restricted Stock Agreement entered into on July 1, 2018.*

10.2

Form of Promissory Note issued on August 31, 2018.*

10.3

Ninth Amendment to Loan and SecurityEmployment Agreement between Accelerize Inc. and SaaS Capital Funding II, LLC,Frank Lane, dated as of August 31, 2018.*

10.4

Third Amending Agreement between Accelerize Inc. and Beedie Investments Limited, dated as of August 31, 2018.*June 21, 2019 (incorporated by reference to the Company’s Current Report on Form 8-K filed on September 19, 2019).

 

 

31.1

Certification of Principal Executive Officer Pursuant to Rule 13a-14(a) and15d-14(a).*

31.2

Certification ofand Principal Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a)and15d-14(a).*

  

  

32.1

Certification of Principal Executive Officer Pursuant to 18 U.S.C. 1350.**

32.2

Certification ofand Principal Financial Officer Pursuant to 18 U.S.C. 1350.**

 

 

101.

The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2018,2019, formatted in XBRL (eXtensible Business Reporting Language): (i) the Balance Sheets, (ii) the Statements of Operations, (iii) the Statements of Comprehensive Loss, (iv) the Statements of Changes in Stockholders’ Deficit, (v) the Statements of Cash Flows, and (v)(vi) related notes to these financial statements.*

 

*

Filed herewith.

**

Furnished herewith.

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  

ACCELERIZECFN ENTERPRISES INC. 

  

  

  

  

  

Dated: November 14, 20186, 2019

By:

/s/ Brian Ross                                                               

  

  

  

Brian Ross

President and Chief Executive Officer

(Principal Executive Officer)Officer and Principal

Dated: November 14, 2018

By:

/s/ Anthony Mazzarella

Anthony Mazzarella

Chief Financial Officer

(Principal Financial Officer)

  

 

32

 

32